Volatile Organic Compound Detection And Disease Diagnostics Using Dna-Functionalized Carbon Nanotube Sensor Arrays by Kehayias, Christopher Erkki
University of Pennsylvania 
ScholarlyCommons 
Publicly Accessible Penn Dissertations 
2020 
Volatile Organic Compound Detection And Disease Diagnostics 
Using Dna-Functionalized Carbon Nanotube Sensor Arrays 
Christopher Erkki Kehayias 
University of Pennsylvania 
Follow this and additional works at: https://repository.upenn.edu/edissertations 
 Part of the Condensed Matter Physics Commons 
Recommended Citation 
Kehayias, Christopher Erkki, "Volatile Organic Compound Detection And Disease Diagnostics Using Dna-
Functionalized Carbon Nanotube Sensor Arrays" (2020). Publicly Accessible Penn Dissertations. 4133. 
https://repository.upenn.edu/edissertations/4133 
This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/4133 
For more information, please contact repository@pobox.upenn.edu. 
Volatile Organic Compound Detection And Disease Diagnostics Using Dna-
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Abstract 
There is a strong desire for novel chemical sensors that can detect low concentrations of volatile organic 
compounds (VOCs) for early-stage disease diagnostics as well as various environmental monitoring 
applications. The aim of this thesis work was to address these challenges by developing an “electronic 
nose” (e-nose) platform based on chemical sensor arrays capable of detecting and differentiating 
between various VOCs of interest. Sensor arrays were fabricated in a field-effect transistor (FET) 
configuration with exquisitely sensitive carbon nanotubes (CNTs) as the channel material. The nanotubes 
were functionalized with a variety of single-stranded DNA oligomers, forming DNA-NT hybrid structures 
with affinity to a wide variety of VOC targets. Interactions between DNA-NTs and VOCs yielded changes in 
sensor conductivity that depended strongly on the base sequence of DNA. Arrays of CNT devices were 
functionalized with up to ten different DNA oligomers to enable electronic signature readouts of VOC 
binding events. DNA-NT responses were processed with pattern recognition algorithms in order to 
classify different VOC targets according to their chemical “fingerprints.” This technology was used to 
measure VOC biomarkers associated with ovarian cancer and COVID-19 from human fluid media. DNA-NT 
arrays measured headspaces VOCs from 58 blood plasma samples from individual people, including 15 
with a late-stage malignant form of ovarian cancer, 6 with early-stage malignant cancer, 16 with a benign 
form of cancer, and 21 healthy age-matched controls. Statistical techniques based on machine learning 
were used to discriminate between the malignant, benign, and healthy groups with 90 – 95% classification 
accuracy. Furthermore, all six early-stage samples were correctly identified with the malignant group, 
indicating significant progress towards an effective screening method for ovarian cancer. Similar 
investigations were conducted on sweat samples procured from patients who had tested positive for 
COVID-19 (CoV+) and those who had tested negative (CoV-). Statistical analysis of the DNA-NT responses 
to the sweat headspace VOCs revealed highly differentiated clusters associated with the CoV+ and CoV- 
groups. A binary classifier was constructed using the response data and was estimated to have a 99% 
classification success rate, suggesting strong potential for utilizing DNA-NTs for COVID screening. Finally, 
DNA-NT arrays were assessed based on various performance characteristics desired for remote 
environmental monitoring applications such as pollution monitoring and explosives detection in a 
warzone. A series of experiments was conducted to evaluate DNA-NT sensitivity, specificity, and longevity 
using mixtures of 2,6-dinitrotoluene (DNT) and dimethyl methylphosphonate (DMMP) to simulate 
complex VOC environments. The sensors demonstrated sensitivity to parts-per-billion concentrations of 
DNT in a highly concentrated background of DMMP. Moreover, the shelf life of these sensors was 
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VOLATILE ORGANIC COMPOUND DETECTION AND DISEASE DIAGNOSTICS USING DNA-
FUNCTIONALIZED CARBON NANOTUBE SENSOR ARRAYS 
Christopher E. Kehayias 
A. T. Charlie Johnson 
 
There is a strong desire for novel chemical sensors that can detect low concentrations of 
volatile organic compounds (VOCs) for early-stage disease diagnostics as well as various 
environmental monitoring applications. The aim of this thesis work was to address these 
challenges by developing an “electronic nose” (e-nose) platform based on chemical sensor 
arrays capable of detecting and differentiating between various VOCs of interest. Sensor 
arrays were fabricated in a field-effect transistor (FET) configuration with exquisitely 
sensitive carbon nanotubes (CNTs) as the channel material. The nanotubes were 
functionalized with a variety of single-stranded DNA oligomers, forming DNA-NT hybrid 
structures with affinity to a wide variety of VOC targets. Interactions between DNA-NTs 
and VOCs yielded changes in sensor conductivity that depended strongly on the base 
sequence of DNA. Arrays of CNT devices were functionalized with up to ten different 
DNA oligomers to enable electronic signature readouts of VOC binding events. DNA-NT 
responses were processed with pattern recognition algorithms in order to classify different 
VOC targets according to their chemical “fingerprints.” This technology was used to 
measure VOC biomarkers associated with ovarian cancer and COVID-19 from human fluid 
media. DNA-NT arrays measured headspaces VOCs from 58 blood plasma samples from 
individual people, including 15 with a late-stage malignant form of ovarian cancer, 6 with 
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early-stage malignant cancer, 16 with a benign form of cancer, and 21 healthy age-matched 
controls. Statistical techniques based on machine learning were used to discriminate 
between the malignant, benign, and healthy groups with 90 – 95% classification accuracy. 
Furthermore, all six early-stage samples were correctly identified with the malignant group, 
indicating significant progress towards an effective screening method for ovarian cancer. 
Similar investigations were conducted on sweat samples procured from patients who had 
tested positive for COVID-19 (CoV+) and those who had tested negative (CoV-). 
Statistical analysis of the DNA-NT responses to the sweat headspace VOCs revealed 
highly differentiated clusters associated with the CoV+ and CoV- groups. A binary 
classifier was constructed using the response data and was estimated to have a 99% 
classification success rate, suggesting strong potential for utilizing DNA-NTs for COVID 
screening. Finally, DNA-NT arrays were assessed based on various performance 
characteristics desired for remote environmental monitoring applications such as pollution 
monitoring and explosives detection in a warzone. A series of experiments was conducted 
to evaluate DNA-NT sensitivity, specificity, and longevity using mixtures of 2,6-
dinitrotoluene (DNT) and dimethyl methylphosphonate (DMMP) to simulate complex 
VOC environments. The sensors demonstrated sensitivity to parts-per-billion 
concentrations of DNT in a highly concentrated background of DMMP. Moreover, the 
shelf life of these sensors was projected on the order of months, making DNA-NTs 
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CHAPTER 1: Overview of the Thesis 
 
There is an ever-increasing need for vapor-phase chemical sensors in biomedical 
applications including early-stage disease diagnostics or environmental monitoring 
applications such as pollution detection. Until recently, few technological advancements 
have been able to effectively respond to these needs because such applications demand 
high sensitivity to a wide variety of volatile organic compounds (VOCs) as well as fast 
response times and long sensor lifetimes. The emergence of nano-bio hybrid materials has 
stirred much excitement within the chemical sensing community due to the combined 
sensitivity of novel nanomaterials such as carbon nanotubes and graphene with various 
biomolecules with tunable affinities towards specific or a wide range of target vapor 
analytes. Electronic systems based on nano-bio materials are uniquely well-suited for 
chemical sensing applications due to their exquisitely high surface-to-volume ratios, 
ensuring that electronic transport activity occurs in close proximity to chemical binding 
events that take place on the material surface. This work focuses on the development of an 
electronic nose system based on DNA-functionalized carbon nanotube field-effect 
transistors and the evaluation of this system for ovarian cancer diagnosis of human blood 
plasma samples, COVID-19 screening based on human sweat, and various performance 
characteristics desirable in environmental monitoring applications. 
Chapter 2 of this thesis discusses the importance of detection systems based on 
olfaction and motivates the development of vapor sensing technology due that can operate 
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at the same proficiency as mammalian olfactory systems. Electronic nose systems based 
on DNA-functionalized carbon nanotube (DNA-NT) vapor sensors are introduced. The 
electronic properties of carbon nanotubes are discussed, motivating their use in chemical 
sensing applications due to their remarkable sensitivity. The field-effect transistor (FET) 
architecture of DNA-NT sensor arrays is presented and an overview of their operability is 
provided. Chemical functionalization of the nanotubes (NTs) via single-stranded DNA is 
covered, as is the interaction between target VOCs and the DNA-NT hybrid structures. The 
Hill-Langmuir theory of binding dynamics is proposed as a model for VOC binding events 
and is used to explain the relationship between variations in target concentrations and 
DNA-NT conductivity. Finally, statistical analysis techniques based on two machine 
learning algorithms, principal component analysis (PCA) and linear discriminant analysis 
(LDA), are summarized with more vigorous derivations found in the Appendix of this 
thesis. Binary classification based on receiver operating characteristics (ROCs) are also 
introduced. 
Chapter 3 describes electrode fabrication processes for FET arrays based on 
photolithography as well as procedures for deposition of the carbon nanotubes across the 
FET channels and chemical functionalization via single-stranded DNA. Electrical 
characterization of DNA-NT arrays is presented. General experimental procedures and data 
acquisition protocols are also introduced, as are data processing techniques. An overview 
of the equipment used in each experiment is also included. 
Chapter 4 discusses the challenge of early-stage diagnosis of ovarian cancer and 
motivates the development of a reliable screening technique to improve the survivability 
3 
 
of patients who develop this disease. A collaboration between Penn Hospital, the Johnson 
Group, the Penn Vet Working Dog Center and the Monell Chemical Senses Center is 
presented with the aim of analyzing VOCs from human blood plasma associated with 
ovarian cancer patients as well as healthy controls using three different approaches: (1) 
analytical chemistry using gas chromatography / mass spectrometry to identify differences 
in VOC composition between diseased and healthy blood; (2) training of sniffer dogs to 
identify blood samples as diseased or healthy based on their odors; and (3) using DNA-NT 
arrays to differentiate between VOC signatures associated with cancerous and non-
cancerous individuals. This chapter focuses on the third approach. DNA-NT measurements 
of headspace VOCs from pooled plasma and plasma from individuals are described. Data 
processing and classification of the sensor response data using LDA is presented. Cross-
validation techniques are introduced to test the statistical robustness of the LDA-based 
classifiers. Lastly, modifications to the experimental procedure in order to accommodate 
challenges measure plasma VOCs are discussed. 
Chapter 5 introduces a collaboration between the Johnson Group and Rohinton 
Mehta’s group from X Development with the aim of evaluating DNA-NT sensitivity, 
ability to detect low-concentration targets in a complex background, response times, and 
longevity. Experiments involving a newly fabricated DNA-NT array are described in 
which array is exposed to multiple different concentrations of 2,6-dinitrotoluene (DNT), a 
compound known to have a relatively low vapor pressure. Additional experiments 
involving parts-per-billion concentrations of DNT diluted in a highly concentrated 
background of dimethyl methylphosphonate (DMMP) are discussed. Similar experiments 
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are presented in which the fresh DNA-NT array is replaced with one that was prepared four 
months prior. Special data processing techniques using boxcar smoothing to assist in 
resolving low-concentration signals are introduced. Conclusions are made is assessment of 
the DNA-NT performance in all experiments. 
Chapter 6 discusses the deadly implications of the new COVID-19 disease and 
drawbacks of current screening procedures. An investigation involving DNA-NT 
discrimination of VOCs from human sweat procured from COVID-positive (CoV+) and 
COVID-negative (CoV-) volunteers is described. LDA processing of the ensuing response 
data is presented, revealing promising separation between the CoV+ and CoV- groups. 
Sensitivity and specificity estimates are presented for a binary classifier based on the LDA 
results, as are estimates of the overall classification accuracy using a ROC curve. 
Chapter 7 includes a summary of the thesis, along with a discussion of future 
prospects and developments needed to convert our apparatus into a reliable technology for 





CHAPTER 2: Principles of Electronic Nose Chemical 
Sensors 
 
In this chapter, we discuss the motivation and advantages of developing an 
electronic nose (e-nose) technology to explore volatile signatures appropriate for a diverse 
set of applications. This technology can probe the relatively untapped wealth of 
information found in chemical signatures based on volatile organic compounds (VOCs) 
produced from various biological and industrial sources, potentially leading to new and 
compelling applications. 
Section 2.1 describes the e-nose concept and its advantages over other chemical 
sensing techniques. We introduce an e-nose based on a large array of diversified chemical 
sensors that produce a unique olfaction response to a given target analyte. The sensing 
medium is a combination of highly sensitive carbon nanotubes and single-stranded DNA 
that induces an affinity to a wide variety of VOCs.  
In Section 2.2, we discuss the properties of carbon nanotubes. These are 
nanostructures that are exquisitely sensitive to changes in their local environment, making 
them ideal candidates for chemical sensing applications. Section 2.3 outlines how we 
combine carbon nanotubes with field effect transistors to form chemical sensors with an 
electronic readout. A “chemical gating” mechanism is proposed as the interaction between 
target analytes and the carbon nanotubes that produces a measurable electrical response. 
Chemical functionalization with single-stranded DNA is also described. 
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Section 2.4 introduces the Hill-Langmuir model that describes binding dynamics 
between chemical receptors and target species. Finally, Section 2.5 outlines basic 
principles of machine learning algorithms used to perform pattern recognition and 
statistical analysis on our e-nose response data to identify the chemical signatures of 
various VOCs of interest. 
 
2.1 Introduction to Electronic Nose Systems 
 
The important role olfaction plays in the survival of living creatures can hardly be 
overemphasized. One of nature’s oldest senses, olfaction enables a lifeform to detect and 
characterize traces of molecules in the air that indicate the presence of food, danger, or 
potential mates.1 In nature, many such molecules are volatile organic compounds (VOCs) 
produced metabolically by plants and animals. VOCs are compounds that have relatively 
high vapor pressure and low water solubility for standard temperatures.2 Generations of 
evolution have shaped olfaction mechanisms in a variety of organisms into highly 
successful chemical sensing systems able to discriminate between VOCs with remarkable 
precision.3-4 
Compared to countless advancements inspired by our visual and auditory systems, 
progress towards a technological equivalent of a nose has been relatively slow. Currently, 
our most reliable chemical vapor sensor is the canine. Dogs’ noses have about 300 million 
olfactory receptors represented by 1100 unique olfactory receptor proteins (ORPs) 
compared to six million sensors and 350 ORPs for humans, and thus dogs are able to 
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identify a much wider variety of VOC targets.5 Dogs’ noses are also 10,000 – 100,000 
more sensitive than our own, able to  detect VOCs at sub-parts per trillion levels.6-7 Sniffer 
dogs are highly successful in applications ranging from tracking odor signatures of missing 
personnel to detecting explosives or narcotics. However, using sniffer dogs in analytical 
applications is not as ideal. Unlike scientific instruments, a sniffing dog requires long-term 
professional training and its chemical “readout” is an anecdotal interpretation of its 
behavior. Often, the dog’s response is ineffectively communicated to its trainer and can be 
influenced by fatigue or short attention span.8 Moreover, it is practically impossible to 
determine which chemical compounds in particular are triggering the dogs’ responses.8 
A more scientifically robust approach is found in today’s electronic nose (e-nose) 
sensors. An e-nose is a device that incorporates electronic sensor arrays with pattern 
recognition systems to detect and discriminate between various odors.9 The architecture of 
e-nose systems is inspired by mammalian olfaction, making use many different types of 
cross-selective olfactory receptors that produce diversified electronic outputs upon 
exposure to a broad range of VOC analytes.9-10 These outputs are then recorded in a 
computer database and processed using pattern recognition and statistical analysis 
algorithms. The first e-nose was developed in 1982 based on three varieties of 
semiconductor transducers with broad, overlapping chemical selectivity.11 The sensing 
material was composed of conductive carbon black coatings coupled with insulating 
polymers. Adsorption of VOCs would cause the material to swell, causing a measurable 
decrease in its conductivity. Unfortunately, these early e-nose sensors could only 
differentiate between certain hydrophilic and hydrophobic molecules – nevertheless, their 
8 
 
emergence sparked the development of increasingly sophisticated e-nose designs with 
recent progress towards explosives detection and environmental monitoring 
applications.12-14 
In more recent years, e-nose gas sensors have also become popular candidates as 
detectors for VOC disease biomarkers.15-16 Disease monitoring based on VOC biomarkers 
poses the additional challenge that the target molecules are very complex chemically.17 To 
differentiate between these targets requires sensing materials that can accommodate such 
complexity. Fortunately, many biomolecular compounds are available that have natural 
affinity to biomarkers. These biomolecules can either be borrowed from nature, such as 
DNA or protein antibodies produced by the body, or engineered to serve a particular 
function.18-19 In addition, biomolecules can be chemically linked to electronic materials 
such as novel nanomaterials that possess exquisitely sensitive electronic properties.18, 20 
Nanomaterials are a natural choice for chemical sensing applications because they exhibit 
large surface-to-volume ratios and are atomically thin, thus confining charge carrier 
transport to the material surface where interactions with the environment take place.21 
This thesis work makes use of an e-nose system based on arrays of single-walled 
carbon nanotube field-effect transistors (NTFETs). A field-effect transistor (FET) is a 
three-terminal device in which the conduction between a source and a drain electrode pair 
is modulated by a voltage applied to a third gate electrode. A special electrode layout for a 
NTFET sensor array was designed to accommodate multiple sensor types that would 
respond simultaneously to target analytes (Figure 2.1a). A given array comprises 100 
NTFETs divided into ten groups of ten sensors each (Figure 2.1b). Each group is 
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chemically functionalized with an oligomer of single-stranded DNA with a different base 
sequence to induce differential affinity to a wide range of VOC targets.22-23 The sensor 
arrays are exposed to target biomarkers of interest using a home-built gas-delivery system. 
VOC analytes that adsorb onto the DNA-nanotube (DNA-NT) hybrid structures elicit 
electrical responses from the CNTs that are recorded and stored in a computer. The data is 
later processed using pattern-recognition algorithms to identify informative features useful 
for discriminating between different VOCs. 
 
 
Figure 2.1. (a) Electrode layout for an array of 100 NTFETs partitioned into ten groups of ten 
devices each. The ten groups are arranged in staggered columns, facilitating individual 
functionalization with ten different DNA oligomers without cross-contamination between groups. 
Source and drain electrodes are positioned at the top of each column (one region circled in red). 
Directly below are square contact pads for external measurement. (b) Microscope image of ten 
DNA-NT devices composed of ten drain electrodes and one common source electrode arranged 
in an interdigitated finger configuration. (c) Scanning electron microscopy image of a channel 




2.2 Principles of Carbon Nanotubes 
 
2.2.1 Overview of Single-Walled Carbon Nanotubes 
Single-walled carbon nanotubes (SWCNTs) are carbon allotropes with tubular 
structures that have diameter length scales on the order of nanometers. Each SWCNT is 
composed of a single-atomic layer of sp2-hybridized carbon atoms arranged in a hexagonal 
“honeycomb” lattice. We can immediately draw a similarity to the structure of graphene 
which is a planar lattice of carbon atoms also arranged in a honeycomb lattice.24 The 
geometry of a SWCNT can be imagined by rolling a graphene sheet along a certain axis 
into a cylinder with seamlessly-bonded carbon atoms forming the surface. In order to 
preserve the lattice periodicity on the SWCNT, only certain choices for the rolling direction 
are allowed. This direction is called the chiral vector and the discrete set of geometric 
conformations for SWCNTs are known as chiralities. 
It is possible to obtain multi-walled carbon nanotubes (MWCNTs) in which several 
coaxial SWCNTs of varying diameters are merged into a single structure.25 However, I 
only used SWCNTs throughout my PhD research – hence, I will refer to SWCNTs simply 
as CNTs for the remainder of this dissertation. 
 
2.2.2 Semiconducting Carbon Nanotubes 
The dimensions and chirality of a CNT play crucial roles in determining its 
electronic properties. Given two linearly independent translation vectors on the graphene 
lattice, ?⃑? 𝟏 and ?⃑? 𝟐, the chiral vector of a CNT, ?⃑⃑? , is represented by 
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 ?⃑⃑? = 𝑛?⃑? 𝟏 + 𝑚?⃑? 𝟐 (2.2.1) 
 
where n and m are integers. The chirality of a given CNT is commonly represented using 
the shorthand (𝑛,𝑚). Conventionally, n is positive with 𝑛 ≥ 𝑚. Two special cases include 
the “zigzag” chirality, where 𝑚 = 0, and “armchair” CNTs in which 𝑛 = 𝑚 (Figure 2.2). 
The diameter, d, of a (𝑛,𝑚) CNT is given by the following formula: 
 
 𝑑 = 𝑎√3(𝑛2 + 𝑛𝑚 + 𝑚2)/𝜋 (2.2.2) 
where 𝑎 = 1.42 Å is the interatomic distance between adjacent carbon atoms.25  
 
 
Figure 2.2. The hexagonal “honeycomb” lattice of the graphene structure (left) can be 
mathematically represented by the translation vectors ?⃑? 𝟏 and ?⃑? 𝟐. Single-walled carbon 
nanotubes (SWCNTs) can be constructed by rolling ribbon-like subsets of this lattice (indicated 
by the dashed edges) into cylinders with circumference |?⃑⃑? | = |𝒏?⃑? 𝟏 + 𝒎?⃑? 𝟐| where n and m are 




 The chirality of a CNT can indicate whether it behaves as a metal or semiconductor. 
Semiconducting CNTs are far more desirable for use in our e-nose because their 
conductances vary drastically when exposed to nearby VOC analytes compared to only 
negligible changes for metallic CNTs. A (𝑛,𝑚) CNT is metallic if 𝑛 = 𝑚 or quasi-metallic 
with a very small bandgap if 𝑛 − 𝑚 is a multiple of 3 with 𝑛 ≠ 𝑚 and 𝑛𝑚 ≠ 0; a 
semiconducting CNT results in all other cases.25-26 
The vapor sensors used in this thesis work were fabricated using a solution of 98% 
semiconducting CNTs suspended in an aqueous solution purchased from NanoIntegris Inc. 
(Quebec, Canada). From an electronic transport point of view, these CNTs are essentially 
one-dimensional structures since they are quantum-confined spatially in two dimensions.27 
An elementary result from solid state physics reveals that the electronic density of states, 
𝐷(𝐸), for a one-dimensional potential takes the following form: 
 
where 𝑚𝑒 is the electron mass, 𝐸 is its energy and 𝐸𝑐 is the minimum energy of a given 
subband.25 The 1/√𝐸 relationship yields a series of discontinuities in  
𝑑𝐷(𝐸)
𝑑𝐸
  called Van 
Hove singularities that indicate energies within a subband that have a large number of 
available states (Figure 2.3). The first Van Hove singularity below the Fermi energy 
coincides with the edge of the valence band which consequently corresponds to a large 
number of available hole states (the CNTs used in this work are p-type so holes are the 
majority charge carrier). The number of holes occupying these states can be increased with 







(𝐸 −  𝐸𝑐)−1/2 (2.2.3) 
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roughly 1 pA. This phenomenon is enabled by the field effect which will be described in 
the following section. 
 
Figure 2.3. The density of electronic states 𝑫(𝑬) for a semiconducting (6,5) CNT with a diameter 
of approximately 1 nm. As a consequence of this nanoscale confinement, the conduction and 
valence bands are divided into subbands that take the form 𝑫(𝑬) ∝ 𝟏/√𝑬. A series of Van Hove 
singularities occur at energies where 
𝒅𝑫(𝑬)
𝒅𝑬
 diverges. These are energies for which a large 
number of electronic states are available per unit energy. This figure was adapted from 
http://www.photon.t.u-tokyo.ac.jp/~maruyama/kataura/kataura.html. 
 
2.3 Carbon Nanotube-Based Sensor Arrays 
 
2.3.1 Field and Chemical Gating of Carbon Nanotube Field-Effect Transistors 
The e-nose sensor arrays utilize semiconducting CNTs in a field-effect transistor 
(FET) configuration. CNTs are deposited between source and drain electrodes patterned 
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onto Si/SiO2 substrates, forming a NTFET (Figure 2.4a). A fixed source-drain bias (VSD) 
is applied to generate a hole current (ISD) through the NTFET channel which is measured 
in real time with an ammeter. A gate potential (VG) is simultaneously applied to the 
underside of the substrate. The Si layer is heavily p-doped which effectively allows charge 
carriers to transport through the material as they would in a conductor. Hence, the holes 
near the CNT layer are capacitively coupled to the gate potential with the oxide layer in 
between serving as a dielectric. A negative gate potential will drive electrons to occupy the 
Si layer near the oxide which draws holes from the source electrode to match the change 
in opposing charge. The additional holes increase the local hole concentration, ultimately 
increasing the conductivity of the p-type CNTs. Similarly, a positive VG will deprive the Si 
layer of electrons, thus depleting the local hole concentration near the CNTs and ultimately 
decreasing the overall device conductivity. This is demonstrated in an I − VG characteristic 
where ISD for an NTFET is measured as a function of a varying VG (Figure 2.4b). 
 
 
Figure 2.4. (a) A semiconducting CNT is contacted by a source and a drain electrode on a Si/SiO2 
substrate. A source-drain bias, 𝐕𝐒𝐃, generates a current, 𝐈𝐒𝐃, through the NTFET channel. This 
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current is modulated by a gate potential 𝐕𝐆, applied to the underside of the p-doped Si layer. (b) 
𝐈 − 𝐕𝐆 characteristic of a single NTFET depicting the source-drain current as 𝐕𝐆 is swept from 
−𝟐𝟎𝐕 to +𝟐𝟎𝐕 and back to −𝟐𝟎𝐕 as indicated by the blue arrows. The discrepancy between the 
forward and reverse sweeps is due to a hysteresis effect.28 
 
2.3.2 DNA Functionalization of NTFETs 
NTFET conductance is also affected by VOC analytes in close proximity to the 
CNTs via “chemical gating.” Though the mechanism is not fully understood, it is believed 
that certain VOCs will either donate or accept electrons to or from the CNTs, varying the 
local charge carrier concentration and thus causing a shift in ISD from its baseline value.
29 
Other VOCs are thought to dissociate in the presence of an interfacial water layer, leaving 
behind charged molecules that vary the hole density due to electrostatics.29 
The sp2-hybridized CNT structure offers a lacking diversity of interactions with 
VOCs, limiting the range of detectable VOCs.30 Hence, the CNTs are functionalized with 
single-stranded DNA oligomers of a particular base sequence that introduce binding sites 
for chemical sensing.30 DNA oligomers adhere onto CNT sidewalls via π – π stacking 
interactions, forming DNA-NT hybrid structures. This is a relatively strong chemical 
attraction that does not interfere with the covalent carbon-carbon bonds of the CNT, thus 
preserving the desirable electronic sensitivity of the overall structure.31 Furthermore, the 
DNA oligomers assume sequence-specific conformations with loop and hairpin structures 
that enable diversified interactions between VOC analytes and the DNA-NT structures.30, 
32-34 The sensor arrays used in this research were functionalized with ten DNA oligomers 
21 – 24 bases long (see Chapter 3, Table 3.1), offering a vast wealth of geometrical and 
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chemical complexity that is similarly enjoyed by olfactory receptor proteins found in 
nature. The base sequences of these oligomers are random, though in principle they can 
also be engineered to have targeted affinities towards certain types of VOC analytes of 
interest.22-23 Moreover, customized oligomers of single-stranded DNA are easily accessible 
and can be purchased inexpensively from biotechnology vendors such as ThermoFisher 
(Waltham, MA) for roughly one US dollar per base. 
For a typical experiment, a DNA-NT array is exposed to a mixture of VOC analytes 
and water vapor diluted in nitrogen gas. Based on thermodynamics studies of similar 
sensing mechanisms, it is hypothesized that the VOCs are solubilized by water molecules 
that form an interfacial layer with the DNA structures, enabling an interaction between the 
analytes and the DNA (Figure 2.5a).35-36 The VOCs can acquire a charge via dissociation 
or ionization, or possibly by exchanging electrons with the DNA-NT hybrid structure. The 
DNA-NT fabrication process is designed to limit the DNA functionalization layer to 
nanoscale thickness, ensuring that target binding events are in close proximity to the CNT. 
The result is an amplified electrostatic interaction between the charged VOCs and the 
CNTs, causing measurable shifts in device currents from baseline. Earlier investigations 
demonstrated that propionic acid, a known proton donor, evoked positive shifts in DNA-
NT currents from baseline,30 suggesting that a negatively-charged layer of deprotonated 
propionic acid ions evoked an increase in CNT hole concentration (Figure 2.5b).30 The 
same study also demonstrated that dimethyl methylphosphonate (DMMP), a strong 





Figure 2.5. (a) A NTFET, depicted by a single CNT for simplicity. The CNT is functionalized with 
a single-stranded DNA oligomer of a particular base sequence (blue and green structure) forming 
a DNA-NT hybrid material. Target VOCs (red) interact with DNA binding sites and are adsorbed 
onto the DNA-NT. (b) A single DNA-NT sensor is exposed to a two-minute pulse of hydrated 
propionic acid. A positive fractional current response ensues, presented as ∆𝐈/𝐈𝟎 where 𝐈𝟎 is the 
baseline current. The DNA-NT is subsequently refreshed with nitrogen gas at the same relative 
humidity to remove desorbing VOCs, essentially recovering the device current to baseline. (c) 
The same DNA-NT was exposed to dimethyl methylphosphonate (DMMP) in the same manner, 
which elicits a negative shift in current relative to baseline. 
 
2.4 Hill-Langmuir Binding Dynamics 
 
The binding interaction between single-stranded DNA and target VOCs is 
analogous to the binding dynamics of certain protein complexes in which ligand molecules 
18 
 
link to one or more receptors on a biomolecule to activate a particular biological function 
such as various types of molecular machinery within a living cell.38-42 The physical 
mechanism of such systems can be modeled using Hill-Langmuir analyte binding dynamics 
inspired by a simplified system of ligands occupying substrate-dwelling receptors or 
binding sites (Figure 2.6). In our case, the ligands are VOCs occurring at a fixed 
concentration, c, which is large enough such that VOC binding events cause a negligible 
decrease in c. 
 
Figure 2.6. An array of receptors (yellow) is exposed to VOC ligands (blue) at a fixed 
concentration. Some of the ligands bind with receptors to form receptor-ligand protein 
complexes. 
  
Once a ligand is bound to a receptor, the substrate’s affinity for binding another 
VOC depends on the cooperativity of binding, n. Positively cooperative binding occurs 
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when n > 0 in which one adsorbed ligand increases the substrate’s affinity while negatively 
cooperative binding occurs for n < 0 in which the affinity decreases. The binding is said to 
be noncooperative for n = 0 if the affinity is independent of already-bound ligands. The 
fractional occupancy, θ, is defined as the fraction of receptors with bound ligands. When 
the system is in thermal equilibrium, θ will reach a steady-state value given by the Hill 
equation:
 
where 𝐾𝑎 is the VOC concentration for which half the binding sites are occupied and n is 
the Hill coefficient describing the cooperativity of binding. Ka and n are generally obtained 
experimentally by fitting chemical response data to (2.4.1) for multiple values of c (Figure 
2.7). 
 
Figure 2.7. Hypothetical Hill-Langmuir curves outline the relationship between the fractional 
occupancy, θ, and the ligand concentration, c, for two different values of the Hill coefficient, n. 
Ka = 1 µM for both curves, the concentration at which θ is equal to one half. The colored dots 









DNA-NT responses in equilibrium (i.e. responses that reach a stable value) are proportional 
to θ since ∆I/I0 depends on the number of adsorbed VOCs. Thus, a given DNA-NT’s 
sensitivity to changes in VOC concentration is strongly related to the mutual affinity 
between the DNA and the VOCs which is reflected by Ka and n. 
 
2.5 Introduction to Machine Learning Algorithms 
As was discussed in Section 2.1, an electronic nose consists of an array of 
chemically diverse sensors that can discriminate between a vast set of VOCs. Ideally, each 
DNA oligomer contributes some orthogonal information about a target odor signature that 
enhances the discrimination power, or “chemical resolution,” of the e-nose. Thus, there is 
an apparent advantage for e-nose systems that incorporate a large number of distinct sensor 
types.43-44 A consequence of this, however, is that the ensuing high-parameter sensor output 
is necessarily complex, making it challenging to extract useful information out of it using 
conventional data analysis techniques. First-principles investigations of the system’s 
behavior are only possible for drastically simplified models. Meanwhile, graphical 
visualization is generally fruitless because DNA oligomers have largely overlapping 
selectivity, thus any informative features are generally obscured by high parameter 
correlation. A specialized statistical approach is needed to analyze the NTFET response 
outputs. 
Fortunately, there are numerous computational tools available for constructing 
predictive models in exploratory data analysis. Principal component analysis (PCA) and 
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linear discriminant analysis (LDA) are two such algorithms that we have used to analyze 
NTFET array outputs. Both PCA and LDA are linear algebra-based techniques used to 
identify patterns in high-dimensional data sets. In doing so, these algorithms can represent 
the original data with reduced dimensionality, keeping the most important discriminatory 
features. The following sections will review the mathematical foundations of PCA and 
LDA. 
 
2.5.1 Principal Component Analysis (PCA) 
 Principal Component Analysis (PCA) is an unsupervised statistical procedure that 
performs an orthogonal linear transformation on a set of observations of possibly correlated 
variables to convert them into a set of values represented by linearly uncorrelated variables 
called principal components.45-46 This is essentially a change of basis onto a new coordinate 
system such that the first principal component represents the direction with the greatest 
variance when scalar projections of the data lie on this axis. Subsequent principal 
components are associated with lower variances in descending order. Any correlation 
between variables in the original data representation indicates redundancy, and thus the 
data can be simplified by replacing the correlated variables with a single variable. In this 
way, significant trends and features can be revealed using only a few components. 
 Figure 2.8 shows a simulated set of 1,000 DNA-NT responses to a given type of 
VOC. The points are drawn randomly from a bivariate gaussian distribution to represent 
variations in signal due to differences in DNA-NT sensitivities as well as sources of 
random noise. For simplicity, only Seq1 and Seq2 responses are shown. PCA is an 
22 
 
unsupervised algorithm in that no prior knowledge of class distinction between data points 
is assumed. The first principal component, PCA1, maximizes the variance of the overall 
data and is associated with the measurement signal while the orthogonal axis, PCA2, 
represents the weakest correlation and is associated with signal noise. Effectively, the first 
principal component is the axis which maximizes the signal-to-noise ratio for the 
measurements. A more detailed mathematical explanation of PCA can be found in 
Appendix A.1. 
 
Figure 2.8. A simulated set of 1,000 DNA-NT responses are drawn randomly from a bivariate 
Gaussian distribution. Only Seq1 and Seq2 responses are shown for simplicity. The first 
principal component, PCA1, maximizes the variance of the overall data set and is associated with 
the signal while the orthogonal axis, PCA2, represents the weakest correlation and is associated 




2.5.2 Linear Discriminant Analysis (LDA) 
 Like PCA, LDA performs a linear transformation on a dataset to reduce its 
dimensionality and facilitate pattern recognition. LDA is a supervised algorithm that finds 
directions (called linear discriminants) that maximize separation between two or more data 
classes. This is achieved when the separation between the centroids of known class 
distributions is greatest when compared to the measure spread for the two clusters. Figure 
2.9 illustrates two hypothetical distributions of Seq1 and Seq2 responses to two different 
types of VOCs. The measurements would clearly overlap significantly if projected onto 
either the horizontal or the vertical axis which would result in poor separation between the 
clusters. The optimal separation is expressed by projections onto the axis designated by the 
first linear discriminant (see Appendix A.2 for the mathematical foundations for LDA).
 
Figure 2.9. A simulated two-parameter data set with two classes of Gaussian-distributed data 
(red and blue). The distributions overlap significantly along the horizontal and vertical axes. 
Using LDA, one can discover a rotated representation of these axes (shown as the diagonal 
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lines). The distributions on the left show histograms of the data projected onto the 
corresponding axis, resulting in optimized class separation. 
 
A predictive classifier can be constructed by fitting LDA parameters to an existing 
set of class-labeled data points. A multivariate normal distribution is used to model each 
class distribution which assigns a probability to any new data point. The estimated 
classification of the new point is selected based on the class for which this probability is 
the highest. 
 
2.5.3 Receiver Operating Characteristics 
 
The accuracy of a predictive classifier model can be validated using a receiver 
operating characteristic (ROC) curve. Given a collection of measurements of two distinct 
observables, a ROC curve provides an estimate of the classification accuracy of the model 
by comparing the false positive rate (FPR) and true positive rate (TPR) for all possible 
measurement values. This is represented visually in Figure 2.10, where two overlapping 
distributions of measurements for a positive and negative signal (Figure 2.10a) are 
distinguished by sweeping a measurement parameter, ζ, and computing the relationship 
between the FPR and TPR (Figure 2.10b). The area under the curve (AUC) formed by this 
relationship determines the probability of correctly classifying a measurement picked at 





Figure 2.10. Two overlapping distributions of measurements for an imagined two-class system 
are distinguished for every possible value of the measurement parameter, ζ. The colored areas 
represent the true negative (TN), true positive (TP), false negative (FN), and false positive (FP) 
regions for a given ζ. (b) An imagined ROC curve shows the relationship between the false 
positive rate (FPR) and the true positive rate (TPR). The area under this curve (AUC) determines 
the probability of correctly classifying a measurement picked at random. The dashed line 
represents the ROC when the two distributions are perfectly indistinguishable. 
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CHAPTER 3: Device Fabrication, Experimental Methods, 
and Data Processing 
 
In Section 3.1, we discuss the fabrication process of DNA-NT arrays and how we 
utilize them in experiments. Our processes are designed to yield high-yield, ultrasensitive 
chemical sensors using standard and easily reproducible techniques. We fabricate source-
drain electrode pairs on silicon-based substrates using photolithography. A CNT network 
is deposited across the FET channels, each chemically functionalized with single-stranded 
DNA of a particular base sequence. DNA-NT arrays are characterized for quality and 
sensitivity using I-VG sweeps. 
Section 3.2 outlines the vapor delivery system used to expose DNA-NT arrays to 
target VOCs. A home-built experimental setup was is used to house multiple VOC sources 
at a time. A series of computer-automated valves and mass flow controllers deliver the 
volatile headspace of these samples to a specially constructed sensor chamber according to 
a computer-automated protocol. The sensor chamber is fitted with contacts that enable 
rapid, high-precision measurements of 100 DNA-NT currents in real time. 
Section 3.3 describes the typical procedure for collecting DNA-NT chemical 
signature data as well as data analysis methods. DNA-NT arrays are generally exposed to 
a series of pulses of target VOCs from a given sample. A refresh period follows each pulse 
to remove analytes from the system, returning DNA-NTs to a quiescent state. The current 
responses to each exposure are computed as the fractional current shift relative to a baseline 
curve that is fitted to the response data using linear interpolation. Baseline-fitted responses 
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from all DNA-NTs functionalized with the same sequence of DNA are averaged together 
to produce a representative response for that sensor type. 
 
3.1 Fabrication and Characterization of NTFET Sensor Arrays 
 
3.1.1. Photolithographic Patterning of Electrode Arrays 
A standard photolithographic procedure is implemented to fabricate FET electrodes 
using the Quattrone Nanofabrication Facility at the Krishna P. Singh Center (see Appendix 
C for a full detailed description of the procedure). The substrates are standard boron-doped 
<100> silicon wafers, approximately 10 cm (4 inches) in diameter and 500 – 550 µm in 
thickness. Each Si wafer has 285 nm layer of polished dry thermal oxide (SiO2). Prior to 
electrode patterning, 15 nm of Al2O3 is deposited via atomic layer deposition (ALD) on a 
Si/SiO2 wafer (Figure 3.1). This is done because CNTs have improved adhesion to Al2O3 
over the bare SiO2 surface. The wafer is then coated with a positive photoresist, an organic 
material that degrades when exposed to certain wavelengths of light. The wafer is placed 
in a mask aligner where ultraviolet light is passed through a photomask, exposing the 
photoresist only in selected regions. Any exposed resist is dissolved away with a developer, 
leaving behind bare substrate. The entire wafer is then coated with 5 nm Cr followed by 40 
nm of Au using an electron beam physical vapor deposition (EBPVD) system. The Cr layer 
is necessary to increase the adhesion between the oxide and the Au layer. All remaining 
photoresist is dissolved by submerging the wafer into a solvent containing 1-methyl-2-
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pyrrolidinone. Whatever metal not in direct contact with the wafer is lifted off and 
removed, thus leaving behind the desired electrode pattern. 
 
 
Figure 3.1. A standard photolithography process is used to define electrode features on a Si/SiO2 
substrate. Starting at the upper-left diagram, a layer of Al2O3 (shown in blue) is deposited onto 
the substrate to increase its affinity to CNTs. Positive photoresist is then spin-coated uniformly 
onto the substrate. A photomask is placed between the substrate and a source of ultraviolet light, 
blocking selected regions from being exposed. Any photoresist exposed to the light is degraded 
and removed. A layer of Au is evaporated onto the entire wafer. The remaining photoresist is 
lifted off, leaving behind metallized regions in the desired pattern. 
 
Following a successful lithography process, the wafer is diced into individual chips, each 




3.1.2 Deposition and Functionalization of CNTs 
The vapor sensors used in this thesis work were fabricated using a solution of 98% 
semiconducting CNTs suspended in an aqueous solution purchased from NanoIntegris Inc. 
(Quebec, Canada). CNTs dissolved in pure water will tend to aggregate together into bulk 
carbon precipitate that exhibits metallic rather than semiconducting properties. To prevent 
this, the solution contains a water-soluble surfactant that keeps the CNTs separated. The 
CNTs themselves are grown using chemical vapor deposition and placed in solution. Using 
a process known as density gradient ultracentrifugation, the solution is spun in a centrifuge 
at 200,000 rpm over the course of several days to separate CNTs according to diameter 
(Figure 3.2).1 Extracting the proper layer of CNTs from the density gradient yields high-
purity semiconducting CNTs with a relatively uniform distribution of CNT diameters.1 
 
 
Figure 3.2. Density gradient ultracentrifugation is used to separate CNTs according to diameter 




A special procedure is used to deposit CNTs across the source-drain channels of 
each sensor array (see Appendix D for a full description of the process). Approximately 
140 µL of 98% semiconducting CNT solution from NanoIntegris is pipetted onto the 
source-drain regions on each chip and placed in a humid environment for 30 minutes 
(Figure 3.3). A fraction CNTs gradually self-assemble onto the substrate while the 
humidity prevents the solution from evaporating too quickly. This procedure is designed 
to yield a relatively uniform CNT network of an appropriate density (Figure 3.4). The 
residual CNT solution is washed away with isopropanol to remove residual surfactant and 
then again with deionized water to rinse away the isopropanol. The substrate is then 
annealed at 165°C on a hotplate for one hour to improve the contact between the CNTs and 
the electrodes, effectively lowering the electrode contact resistance. 
 
 
Figure 3.3. A sensor array is placed inside an enclosed volume together with a hot water 
container to humidify the environment. CNT solution is deposited across the FET channel 
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regions (outlined in red). The humidity prevents the solution from evaporating while the CNTs 
gradually accumulate onto the substrate. 
 
 
Figure 3.4. Scanning electron microscope images of two representative NTFET channels reveal 
disordered CNT networks forming conductive pathways from source to drain electrodes 
positioned above and below. 
  
A similar procedure is used to functionalize the NTFETs with single-stranded DNA 
of a particular base sequence (see Appendix E for a full description of the process). Ten 
customized DNA oligomers are purchased from Invitrogen (Carlsbad, CA), each a 21- or 








Table 3.1. Ten single-stranded DNA oligomers used to chemically functionalize DNA-NT arrays. 
Each oligomer is a randomized sequence of 21 or 24 nucleotides. 












The DNA is diluted to 100 µM in deionized water, aliquoted, and stored in a -20°C freezer 
until use. One aliquot of each sequence is thawed and a 2 µL droplet is carefully pipetted 
onto each of ten source-drain regions on a DNA-NT array (Figure 3.5). As before, the array 
is placed in an enclosed humid environment for 30 minutes, allowing the DNA oligomers 
to settle out of solution and adsorb onto the CNT surfaces. The droplets are then removed 
from the substrate using compressed nitrogen. 
 
 
Figure 3.5. Ten groups of source-drain regions are functionalized with one of ten oligomers of 
single-stranded DNA. 2 µL droplets are carefully pipetted onto each region, allowing the DNA to 
gradually settle out of solution onto the CNT network on the substrate. This yields a DNA-NT 
hybrid structure only several nanometers in thickness. 
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3.1.3 Electrical Characterization of NTFET Arrays 
DNA-NT arrays are characterized by measuring current-gate voltage (I-VG) 
characteristics using a FormFactor MPS150 probing station. Conductive silver paint is 
applied to the underside of the array to serve as a back-gate contact. The array is placed on 
a metal stage to which is a gate voltage is applied. A customized probe card from Amprobe 
(Everett, WA) is used to interrogate each contact electrode, routing source-drain currents 
to a Keithley 6485 picoammeter as VG is swept from -20 V to +20 V with a fixed source-
drain bias of 0.1 V. Normally, currents converge towards a particular on-state current for 
increasingly negative VG and tend towards a near-zero off-state current for positive VG 
(Figure 3.6a). The overall quality of each array is assessed based on distributions of DNA-
NT on-state currents and on-off ratios. Ideally, on-state currents are significantly larger 
than the noise threshold and generally do not exceed 100 µA. 
 A measure of a DNA-NT’s sensitivity to changes in its electrostatic environment is 
the transconductance, 𝑔𝑚 =
𝑑I
𝑑VG
. Chemical gating due to adsorbed VOCs effectively shifts 
VG from its nominal value which changes the device current by ∆I ≅ 𝑔𝑚∆VG. VG is fixed 




Figure 3.6. (a) I-VG curve for a single DNA-NT shows the relationship between the device current 
and the applied gate voltage. The diagonal green line indicates the steepest slopes in the I-VG 
curve, indicating the gate potential (𝐕𝑮 = −𝟏𝟒𝐕) at which the corresponding device current is 
maximally sensitive to variations in local charge environment. (b) I-VG characteristics for all 100 
devices from the same sensor array. All DNA-NT transconductances are maximized for gate 
potentials between 𝐕𝑮 = −𝟏𝟒𝐕 and 𝐕𝑮 = −𝟏𝟎𝐕. 
 
3.2 Experimental Procedure 
 
A home-built vapor delivery system is utilized to expose sensor arrays to headspace 
VOCs from up to five samples at a time while simultaneously measuring device currents 
in real time (Figure 3.7a). Low viscosity fluids, such as propionic acid or dimethyl 
methylphosphonate, can be placed inside gas bubblers in which headspace VOCs are 
pushed out a side arm by bubbling nitrogen from beneath the liquid level (Figure 3.7b). 
Blood plasma samples have much higher viscosity and are available in low volume (1 mL 
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or less), so they are instead loaded into two-neck round-bottom flasks (Figure 3.7c). Due 
to the relatively low vapor pressures of plasma VOCs at room temperature, the flasks are 
placed in a 50 °C hot water bath to increase the VOC headspace concentration. Micro stir 
bars are included with fluid samples to further promote the release of dissolved VOCs. 
High purity compressed nitrogen gas is delivered to the sample flasks or bubblers to carry 
the headspace VOCs to a stainless steel sensor chamber housing a DNA-NT array. The 
chamber is simultaneously humidified at a fixed relative humidity with water vapor 
generated from a bubbler filled with deionized water to enable VOC adsorption onto the 
DNA binding sites. The chamber is fitted with an intake and exhaust outlet and is open 
from atop to allow placement of a DNA-NT array inside (Figure 3.7d). An acrylic lid fits 
over the top of the chamber and is compressed against an O-ring with screws to prevent 
gas leaks. The lid is equipped with feed-through pogo pins that make electrical contact with 
each DNA-NT, routing current outputs to a National Instruments PXI-2535 switching 
matrix used to cycle through each output to be individually measured by a Keithley 6485 
picoammeter. The base of the chamber is charged to the desired gate voltage using a 
Keithley 617 electrometer. The associated flow rates are regulated using six MKS 1179 
computer-controlled mass flow controllers (MFCs), one for each of the five samples and 
the sixth for the water bubbler. The various components are connected together with ¼” 
Teflon tubing. Portions of the tubing are heated using a heating tape to prevent VOC 
adsorption inside the lines. Three-way solenoid valves (ASCO Valve 8320G202) are used 
to select the VOC headspace of one sample to be measured at a time. These valves are 
actuated electronically via 120VAC solid state relays that are controlled with a computer. 
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A LabVIEW program is used to automate the proceedings of the experiment once it has 
been set up. The program adjusts MFC flow rates and switches valve states according to a 
flow recipe, a precompiled set of instructions that synchronize with a timetable. The 
software also controls bias and gate voltages applied to the sensor array and records source-
drain currents from the picoammeter. This level of automation allows the system to run for 
many hours without user input. 
 
 
Figure 3.7. (a) Schematic overview of the vapor delivery system. Compressed nitrogen is used 
as a carrier gas to deliver VOCs in the headspaces of samples (S1 – S5) to a sensor chamber 
housing a DNA-NT array. The chamber is humidified with water vapor to enable VOC interaction 
with the DNA. Teflon tubing is used to connect the various components together. The gas flow 
rates are regulated using mass flow controllers (MFCs) controlled automatically using a 
computer program. The samples are heated in a hot water bath to promote the generation of 
VOCs. The tubing between the samples and the sensor chamber is also heated (red outline) to 
prevent VOC condensation inside the lines. Computer-controlled valves (yellow structures) are 
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used to select headspace VOCs from one sample to be measured at a time. (b) Two gas bubblers, 
one filled with deionized water for hydration (front). (c) Round-bottom flasks containing blood 
plasma (pale yellow regions) are heated in a hot water bath. Magnetic stirring rods (circled in 
red) are included to agitate the plasma. (d) Sensor chamber fitted with contact pins to read out 
currents from the array of 100 DNA-NTs inside. Three screws compress the top acrylic surface 
against an O-ring, preventing VOCs from leaking outside. 
 
3.3 Data Acquisition Protocol and Data Processing 
The protocol for taking measurements includes a pulse phase, in which a DNA-NT 
array is exposed to a mixture of target VOCs and water vapor diluted in nitrogen gas, and 
a refresh phase, where the mixture is replaced with a stream of nitrogen at the same relative 
humidity (RH) and total flow rate (Figure 3.8a). The purpose of the refresh is to carry away 
residual analytes from the sensor chamber, allowing the DNA-NT currents to recover to 
their baseline value. DNA-NT conductances vary significantly from device to device, 
hence the distribution of baseline currents can span several orders of magnitude (Figure 
3.8b). However, fractional current responses to target VOCs are found to be comparable – 
hence, responses are generally reported as fractional current shifts from baseline, ∆I/I0. 
DNA-NT baseline currents are not constant with time, but rather drift in response to 
changing ambient conditions. We account for this drift by fitting a baseline to each pulse 
measurement using linear interpolation (Figure 3.8c). The fractional current response for 




𝐼𝑀𝑒𝑎𝑠𝑢𝑟𝑒𝑑  −  𝐼𝐵𝑎𝑠𝑒𝑙𝑖𝑛𝑒
𝐼𝐵𝑎𝑠𝑒𝑙𝑖𝑛𝑒
× 100% (3.3.1) 
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Baseline-fitted responses from all DNA-NTs functionalized with the same sequence of 
DNA are averaged together to produce a representative response for that sequence (Figure 
3.8d). Variations on the mean value of ∆I/I0 due to sources of random error are nominally 
reduced by a factor of 1/√𝑛 when averaging responses from n DNA-NTs, thus revealing 
the advantage of devoting many DNA-NTs to each DNA sequence. 
 
Figure 3.8. (a) A single DNA-NT is exposed to a series of two-minute pulses of propionic acid 
mixed with nitrogen at 33% relative humidity (RH). After each pulse, the DNA-NT is flushed with 
nitrogen at the same RH for two minutes, allowing the current to recover. The concentration of 
propionic acid vapor is incrementally increased after every other pulse from 62 ppm to 3100 ppm 
with each increase yielding larger associated responses. (b) Responses from the device in (a) 
(shown in red) are compared to those of 16 other DNA-NTs from the same array (black). Currents 
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are plotted on a logarithmic scale to show that the fractional responses across all devices are 
comparable, even though the magnitudes of baseline currents span several orders of magnitude. 
(c) The current response curve from (a) is baseline-fitted using linear interpolation to account for 
baseline drift. (d) ∆𝐈/𝐈𝟎 for all 17 devices (red traces) with their average superimposed (black). 
The average fractional response exhibits high signal-to-noise ratio.  
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CHAPTER 4: Early-Stage Detection of Ovarian Cancer 
 
 This chapter presents the use of our e-nose technology to screen blood plasma 
samples for volatile indicators of ovarian cancer. Samples were collected from patients 
with a malignant form of ovarian cancer, those suffering from benign ovarian lesions, and 
healthy age-matched women. DNA-NT sensor arrays were exposed to headspace VOCs of 
each sample. The ensuing sensor responses were processed using statistical analysis tools 
which revealed the sensor platform’s capacity to differentiate between metabolic VOCs 
characteristic of healthy individuals and of those suffering from ovarian cancer. 
Section 4.1 proposes a motivation for developing a reliable screening test for 
ovarian cancer, particularly for early-stage cancer when treatments are the most effective. 
Currently, there are no accepted screening tests for ovarian cancer for women of average 
risk. Clinical procedures that reveal ovarian tumors usually do so in the late stages of cancer 
when it is often too late to save the life of the patient. Furthermore, these tests exhibit high 
false positive rates which puts many patients through unnecessary treatment that causes 
significant risks for the patient. Remarkably, several studies have shown that sniffer dogs 
can be trained to differentiate between VOCs from blood plasma and other bodily fluids 
collected from cancer-suffering patients and healthy individuals. E-nose sensor platforms 
based on highly sensitive nanomaterials also show promise in this application, particularly 
for detection of early-stage cases where VOC biomarker concentrations are extremely low. 
 Section 4.2 describes experiments involving blood plasma samples procured from 
(1) patients suffering from malignant ovarian lesions, (2) patients with benign tumors, and 
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(3) age-matched healthy controls. Initial experiments involved three pools of plasma 
samples representing the malignant, benign, and healthy groups. A DNA-NT was 
functionalized with four different DNA oligomers and then exposed to headspace VOCs 
from the pools. The sensor groups produced diversified responses to the VOCs with some 
groups demonstrating promising differentiation between VOCs associated with malignant, 
benign, and healthy groups. Additional measurements were conducted using a DNA-NT 
functionalized with all ten DNA oligomers to probe headspace VOCs from plasma 
collected from 58 individual people. Of these, 21 had a malignant form of ovarian cancer, 
16 suffered from a benign from of cancer, and 21 were healthy controls. A special 
experimental protocol was developed specifically for measuring plasma VOCs to ensure 
reproducibility and signal quality of DNA-NT responses. Once all 58 samples were 
measured, the 10-channel DNA-NT responses were dimensionally reduced using linear 
discriminant analysis (LDA) yielding well-separated response distributions for the healthy, 
benign, and malignant groups. 
 Section 4.3 discusses predictive modeling based on machine learning algorithms to 
enable association of DNA-NT response data with healthy or diseased individuals. 
Classifier models based on four machine learning algorithms – LDA, support vector 
machine (SVM), k-nearest neighbors, and random forest – were constructed using the 
plasma response data as inputs. Each classifier was evaluated based on predictive accuracy 
and robustness using two different cross-validation techniques. All four classifiers 
demonstrated high validation accuracies and relatively low false-positive rates, signifying 
good progress towards a reliable and practical screening technology for ovarian cancer. 
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4.1 An Interdisciplinary Effort Towards Reliable Ovarian Cancer 
Screening 
 
Ovarian cancer is the fifth leading cause of cancer deaths in United States women. 
In 2020 alone, an estimated 13,940 women will have died from ovarian cancer while the 
number of new diagnoses is projected at 21,750.1 This staggering death toll is largely due 
to a complete lack of screening methods for accurate and early detection of the disease. 
The symptoms of ovarian cancer are diverse, non-specific, and commonly mistaken for 
those of other diseases such as various gastrointestinal illnesses.2 More than 80% of 
diagnoses are associated with late-stage ovarian cancer at which point treatments are no 
longer effective – as a result, roughly 70% of patients with late-stage ovarian cancer die 
within 5 years.2 On the other hand, if discovered early, ovarian cancer can be treated 
effectively with a 90% survival rate.3 Any practical test that can more successfully detect 
ovarian cancer in its early stage could significantly increase patient survivability. 
Modern medical diagnostics are largely based on some form of visualization, 
auscultation, or palpation. Currently, discoveries of ovarian tumors are largely achieved 
using some form of medical imaging and clinical laboratory tests. Ultrasound and cancer 
antigen 125 (CA-125) blood tests were once proposed as screening tests for ovarian 
cancer.4 Ultrasound imaging attempts to image tumor masses around a patient’s ovaries 
while CA-125 blood tests can identify individuals that have either healthy or elevated levels 
of the CA-125 protein which could indicate the presence of cancer. Unfortunately, both 
techniques suffer from high false positive rates. Ultrasound cannot distinguish tumors from 
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noncancerous masses and there are many noncancerous conditions that also increase levels 
of CA-125 in blood such as endometriosis and pelvic inflammatory disease. As such, 
neither technique is considered reliable screening techniques for ovarian cancer.5 
In previous centuries, olfaction also played a vital role as doctors would often make 
diagnoses based on their own personal senses of sight, touch, and smell. From an 
evolutionary point of view, olfaction serves as a mechanism for social animals that 
provides a means of communicating information about an individual to others of the same 
species. A diseased individual will sometimes give off a foul odor, causing alarm to its 
surrounding company. Unfortunately, a human’s sense of smell is largely inferior to other 
animals’, and with the emergence of positron emission tomography, ultrasound, liquid 
biopsy and other powerful medical aids, olfaction-based medical practices have been 
falling by the wayside. Only recently have researchers begun revisiting screening strategies 
based on olfaction.6-7 There have been reports of pet dogs behaving differently around their 
owners who were later diagnosed with some form of cancer.6, 8 It is believed that this 
reaction was triggered by the dogs’ ability to detect minute abnormalities in the VOC 
content of bodily odors given off by their owners.8 Though seemingly miraculous, there 
exist scientific theories that offer explanations for remarkable behavior. One such theory 
is that the metabolic byproducts due to cell division differ significantly between tumor cells 
and their healthy counterparts since tumor cells multiply more rapidly and have a higher 
metabolic rate. Some of these byproducts are VOCs that are absorbed into the blood stream 
and distributed to other parts of the body where they can appear in other bodily fluids such 
as sweat, saliva, urine, or tears. Another explanation for this apparent change in VOC 
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content from bodily fluids is due to an immune response to the presence of cancer rather 
than the cancer itself. Numerous studies have validated canines’ ability to detect VOC 
biomarkers associated with a variety of cancers including breast6, bladder9, and ovarian8 
from breath, urine, and blood samples, respectively. 
 A collaboration between the University of Pennsylvania and the Monell Chemical 
Senses Center in Philadelphia is using three approaches to research the differences in odor 
signature in bodily fluids between women diagnosed with malignant ovarian cancer, those 
identified as having benign ovarian tumors, and age-matched healthy individuals. The first 
approach, directed by Dr. Cynthia Otto at the Penn Working Dog Center, involves training 
dogs to identify blood samples as healthy or non-healthy (i.e. cancerous) by sniffing the 
VOCs emitted by blood samples collected from individual people. The second approach 
focuses on using gas chromatography / mass spectrometry (GC/MS) to analyze the 
chemical makeup of characteristic VOCs of cancerous blood samples versus healthy 
samples. The third approach is to develop a laboratory platform based on DNA-NT arrays 
for ovarian cancer screening which is the scope of this dissertation. 
 Samples for this work were procured by our collaborator Professor Janos Tanyi 
through the Ovarian Cancer Center at the University of Pennsylvania Hospital. To ensure 
VOCs were retained for analysis, all samples were spun at 3000 rpm for ten minutes at 4°C 
and then stored frozen at -80 °C. The samples were later defrosted on ice and then divided 
into aliquots of 500 µL. The aliquots were distributed among all collaborators so that all 
samples could be analyzed using the sniffing dogs, GC/MS, and DNA-NT e-nose methods. 
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The aliquots were refrozen at -30 °C and stored until needed. For experiments, samples 
were thawed and then immediately analyzed by the DNA-NTs. 
 
4.2 DNA-NT Measurements of Headspace VOCs from Blood Plasma 
 
4.2.1 Initial Investigations Using Pooled Plasma 
 
The ovarian cancer project was initiated by Dr. Nicholas Kybert, a former Johnson 
PhD student. A preliminary experiment involved three pools of blood plasma procured 
from women with a malignant form of ovarian cancer, women suffering from benign 
tumors, and healthy age-matched controls. Each pool contained 500 µL of plasma from ten 
individual women. The pools were loaded into three separate 25 mL two-neck round-
bottom flasks that were each placed in a 50 °C hot water bath to promote VOC generation. 
Each pool was also agitated with a micro stir bar to further encourage the release of VOCs. 
The flasks were connected to the other e-nose components with Teflon tubing wrapped 
with a heating element to inhibit VOC condensation. An early-generation array of 80 DNA-
NTs was functionalized with four distinct sequences of DNA (Seq1, Seq2, Seq4, and Seq5) 
to probe the VOC headspaces of the three pools. 
Once the samples were brought to temperature, a 30-minute waiting period was 
issued to allow VOCs to accumulate within the headspaces of the flasks. The sensor array 
was then exposed to VOCs from the malignant pool diluted in nitrogen at a 1:4 volume 
ratio. Because plasma is mostly composed of water, the nitrogen component of the mixture 
was humidified to 100% relative humidity (RH). The malignant pulse was sustained for 
two minutes, after which the DNA-NTs were refreshed with 100% RH nitrogen for two 
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additional minutes. VOCs from the benign and healthy pools were measured in the same 
manner. Three measurements were completed for each pool. 
Exposure to plasma VOCs caused a negative shift in DNA-NT currents (Figure 
4.1). Repeated measurements of each sample were closely reproduced and the signal-to-
noise ratios of averaged responses were well above the noise threshold. Seq1 sensors 
demonstrated a remarkable ability to discriminate between the plasma headspaces of each 
pool (Figure 4.1a). Notably, responses to healthy VOCs were consistently the largest in 
magnitude and those associated with malignant pool were always the smallest with the 
benign responses in between. Unlike Seq1, Seq4 responses to malignant, benign, and 
healthy VOCs were far less diverse and hardly demonstrated any ability to distinguish any 
of the pools. The remaining sensors demonstrated some differentiation capacity, though 
neither were as pronounced as Seq1 (Figure 4.1b). Overall, the diversity of responses from 
only four sensor types suggested a strong potential of DNA-NT arrays to discriminate 
between ovarian cancer biomarkers in a complex plasma headspace. 
 
Figure 4.1. (a) Averaged sensor responses (∆𝑰/𝑰𝟎) of 21 Seq1 and 18 Seq4 DNA-NT devices 
exposed to VOCs from the cancerous, benign, and control pools. Three cycles of responses for 
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each pool are shown to show strong reproducibility between repeated measurements. Seq1 
responses demonstrate a strong ability to differentiate between the pools with the healthy pool 
showing the largest responses, malignant showing the smallest, and the benign in between. In 
contrast, Seq4 responses show almost no ability to distinguish them. (b) Responses to all four 
DNA sequences exhibit a diversified olfaction signature of the pooled samples. 
 
4.2.2 Measurement of Blood Plasma from Individuals 
Follow-up measurements were conducted on additional plasma samples collected 
from 58 different people. Of these, 21 had a malignant form of ovarian cancer, 16 suffered 
from a benign from of cancer, and 21 were healthy controls. Six of the malignant samples 
were from women suffering from Stage I or Stage II cancer while the remaining were from 
women with Stage III or IV cancer. As before, each sample was loaded into 25 mL round-
bottom flask and heated in a 50 °C water bath. DNA-NT arrays were coated with all ten 
DNA oligomers listed in Table 3.1 (including the four used in the pooled experiment) and 
then exposed to VOCs according to the same two-minute pulse and two-minute refresh 
protocol used previously (Figure 4.2a). Furthermore, responses from all sensor types 
formed three clusters corresponding to the malignant, benign, and healthy groups (Figure 
4.2b). These clusters overlapped significantly, indicating that effective discrimination of 
VOCs would require the combined efforts of multiple DNA-NT sensor types. This 





Figure 4.2. (a) Average of 9 Seq1 DNA-NT responses exhibit differentiation of headspace VOCs 
from plasma samples derived from three healthy individuals, a patient with benign ovarian 
cancer, and a patient with a malignant form of cancer. Three cycles of measurements are shown 
to demonstrate the reproducibility of responses between repeated measurements. (b) Seq1 
responses for all 58 samples reveal clustering of data within malignant, benign, and healthy 
groups save for one malignant outlier (indicated by the blue arrow). Data points are displayed on 
an arbitrary horizontal axis to aid in visualizing overlapping points. The clusters overlap 
significantly, indicating that further data analysis techniques are needed to improve 
discrimination of each group. 
 
Improved separation between the clusters was achieved using linear discriminant 
analysis (LDA), a predecessor to many advanced machine learning techniques used today 
(Figure 4.3). LDA is a supervised learning algorithm that requires prior knowledge of data 
classification. Hence, the data was supplemented with healthy, benign, and malignant class 
labels which were provided as additional inputs for LDA. No distinction was made to treat 
early-stage and late-stage cancer samples at this time. Projections of data onto the first 
linear discriminant (LDA1) revealed three well-separated distributions corresponding to 
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each class. Remarkably, all early-stage malignant samples were well-situated within the 
malignant distribution, suggesting a strong potential for reliable early-stage detection using 
DNA-NT sensors. 
 
Figure 4.3. DNA-NT responses to headspace VOCs from plasma collected from 58 individuals are 
projected onto the first linear discriminant (LDA1) computed by linear discriminant analysis 
(LDA). 
 
4.2.3 Headspace Regulation of Plasma Samples 
Repeated measurements of plasma headspace VOCs caused a significant 
systematic depletion of DNA-NT baseline currents over the course of each experiment 
(Figure 4.4a). It is not fully understood why this occurs with VOCs associated with blood 
plasma as this phenomenon has not been observed for VOCs from other media. The current 
hypothesis is that this is caused by gradual accumulation of one or more “sticky” molecular 
components of the plasma headspace that are reluctant to desorb from the DNA-NTs, 
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resulting in only partial recovery of device currents after each refresh and thus attenuating 
DNA-NT responses over time (Figure 4.4b). 
 
Figure 4.4. (a) A single DNA-NT sensor is exposed to a series of sixteen exposures to headspace 
VOCs from one blood plasma sample to demonstrate attenuation of both the baseline current 
and the response levels. The start times of the first four exposures are marked by the brown 
arrows. (b) The average current responses of all ten Seq6 devices also demonstrates signal 
attenuation and deteriorating signal-to-noise ratios over time. 
 
A special experimental protocol was developed to reduce the attenuation of DNA-
NT currents due to plasma VOC exposure. Typically, sample VOCs are allowed to 
accumulate within the headspace of the corresponding container between measurements 
(i.e. whenever the system is busy measuring a different sample). This was altered 
specifically for measuring plasma by constantly delivering nitrogen to all sample-
containing flasks throughout all stages of the experiment, effectively reducing the 
associated headspace VOC concentrations. Three-way solenoid valves were used to direct 
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the flow of sample VOCs either to the sensor chamber to be measured or out a separate 
exhaust path (Figure 4.5). 
 
 
Figure 4.5. Modified gas-delivery setup for measuring headspace VOCs from blood plasma 
samples. Nitrogen gas is continuously delivered to all samples throughout the experiment while 
three-way solenoid valves (yellow structures) direct each flow either to the sensor chamber to 
be measured or out a separate exhaust. This decreases the headspace concentrations of plasma 
VOCs which slows the rate of DNA-NT response attenuation. 
 
This technique markedly improved the reproducibility of DNA-NT responses to plasma 
VOCs, nearly eliminating the systematic signal drift observed earlier (Figure 4.6). In 
addition, signal-to-noise ratios remained high above the noise threshold even though the 




Figure 4.6. Nine Seq6 DNA-NTs were exposed to six cycles of measurements of five plasma 
samples in sequence. The samples were measured in the same order for each cycle. The 
responses demonstrate significantly improved reproducibility and a high signal-to-noise ratio. 
 
4.3 Sample Classification Using Machine Learning 
 
4.3.1 Sample Classification Based on Cross-Validation 
Predictive modeling based on pattern recognition algorithms was performed on the 
chemical sensor data to enable association of DNA-NT responses with healthy or diseased 
individuals. Initially, an LDA-based classifier was constructed with the ovarian response 
data using the Scikit-learn package for the Python programming language.10 The 
robustness of the classifier was verified using two cross-validation techniques: Leave One 
Out Cross-Validation (LOOCV) and stratified k-fold cross-validation. Cross-validation is 
often used to test for biased training of a dataset in machine-learning applications. 
LOOCV is designed to test whether or not a single new data point would be 
correctly categorized by the classifier. This is simulated by building the classifier using all 
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but one of the samples in the database. The classifier is then used to predict the identity of 
the left-out sample. This process is repeated until each individual sample in the database 
has been validated. For the ovarian data set, 55 of the 58 samples were correctly identified, 
yielding a validation accuracy of 95% (Table 4.1). Both misclassified samples were false 
negatives with one malignant sample identified as benign and one benign sample identified 
as healthy. All early-stage samples were correctly classified as malignant. 
 
Table 4.1. Results of LOOCV on the entire ovarian dataset. 55 of the 58 samples were correctly 
classified, yielding a validation accuracy of 95%. The three misclassified samples were all false 
negatives with two malignant samples identified as benign and one benign identified as healthy. 
The misclassified malignant sample was from a late-stage cancer patient. 
  CLASSIFIED (LOOCV) 
  Malignant Benign Healthy 
ACTUAL 
Malignant 19 2 0 
Benign 0 15 1 
Healthy 0 0 21 
 
Stratified k-fold cross-validation is a derivative of k-fold cross-validation in which 
a dataset is randomly partitioned into k equal-sized subsets (Figure 4.7). One partition is 
chosen as the validation data while the remaining k – 1 subsets are used as the training data. 
This process is repeated until all partitions have been validated once. Due to the element 
of randomness, it is common practice to repeat the entire k-fold cross-validation process 
multiple times so that the validation results converge towards a representative set of values. 
k-fold cross-validation does not take the classification of each data point into account which 
can be problematic for relatively small data sets since there is a significant chance of obtain 
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training sets that are underrepresented by one or two of the sample groups. A solution is to 
stratify the k partitions such that each subset comprises an equal fraction of data points 




Figure 4.7. Using the stratified k-fold cross-validation technique, the malignant, benign, and 
healthy data are each randomly shuffled and then partitioned into four equal-sized subsets. 
Three subsets from each class are combined to form the training set while the remaining form 
the validation set. The process is repeated until all data points have been validated exactly once. 
 
Stratified k-fold cross-validation was used to partition the ovarian plasma database 
into four subsets, using 75% of the data as the training set with the remaining 25% as the 
validation set. This process was performed 10,000 times to obtain convergent validation 
estimates. On average, 3.76 samples out of 58 were misclassified, corresponding to a 
validation accuracy of 94%. The overall false-positives rate remained low at less than 





Table 4.2. Stratified k-fold cross-validation was performed 10,000 times on the ovarian database. 
The percentages indicate the number of correctly or incorrectly classified samples for each 
corresponding class. The overall validation accuracy was 94% while the overall false positives 




  Malignant Benign Healthy 
ACTUAL 
Malignant 86.0% 13.6% 0.4% 
Benign 0% 93.8% 6.2% 
Healthy 0% 0.5% 99.5% 
 
The classification performances of three additional learning algorithms, each more 
sophisticated than LDA, were also investigated. Support vector machine (SVM), k-nearest 
neighbors (KNN), and random forest were each used to construct new classifiers based on 
the combined dataset. Each algorithm was trained and tested according to LOOCV (Table 
4.3) and repeated stratified k-fold (Table 4.4) cross-validation methods. For the latter, 90% 
of the samples were used for the training set and the remaining 10% for the test set. As 
before, this was repeated 10 times so that each sample was in the testing set exactly once. 
The entire process was repeated 1000 times, shuffling the data each time to form 
independent trials. Again, each independent trial was stratified such that approximately 
equal proportions of malignant, benign, and healthy data were used for the training and 
testing sets for all repeats. In all cases, high validation accuracies were achieved. Despite 
being the least sophisticated algorithm, LDA performed the best in terms of overall 
accuracy, scoring around 95% for both LOOCV and k-fold. The other classifiers achieved 
accuracies of approximately 90%. This is perhaps due to the fact that SVM, KNN, and 
random forest are designed for larger datasets, in which case they may have been 
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overfitting the 58 ovarian responses and compromising the validation accuracies as a result. 
Remarkably, the number of false positives were consistently low in all cases with all 
algorithms successfully classifying 100% of all six early-stage cancer samples with the 
exception of random forest which misclassified one as benign. 
 
Table 4.3. Validation performances for Leave-One-Out Cross-Validation (LOOCV) for LDA, SVM, 
KNN, and random forest classification algorithms. LDA classified all samples with the highest 
accuracy (95%) with zero false positives. 





LDA 55/58 (95%) 21/21 15/16 19/21 0 3 
SVM 52/58 (90%) 20/21 15/16 17/21 1 5 
KNN 53/58 (91%) 21/21 15/16 17/21 0 5 
Random 
Forest 
51/58 (88%) 19/21 14/16 18/21 3 4 
 
Table 4.4. Repeated stratified k-fold evaluation of the same four classification algorithms using 
10 bins and 1000 repeats. 





LDA 54.5/58 (94%) 20.9/21.0 15.0/16.0 18.6/21.0 0.1 3.4 
SVM 52.1/58 (90%) 20.0/21.0 15.0/16.0 17.1/21.0 1.0 4.9 
KNN 52.8/58 (91%) 21.0/21.0 15.0/16.0 16.8/21.0 0.0 5.2 
Random 
Forest 
51.7/58 (89%) 19.5/21.0 14.0/16.0 18.2/21.0 2.4 3.8 
 
4.3.2 Classification Based on Receiver Operating Characteristics 
 
The classification performance of LDA was also verified with receiver operating 
characteristics (ROCs). Normally, ROCs are used to characterize the predictive accuracy 
of a two-class system. Because there are three classes for our database (i.e. healthy, benign, 
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and malignant), three ROC curves were generated using one class as the “positive” signal 
and the other two as the “negative” signal. ROC outputs were based on stratified k-fold 
cross-validation using training / validation splits of 90% / 10% (Figure 4.8a) and 75% / 
10% (Figure 4.8b). In each case, the validation accuracies for the healthy and malignant 
groups were nearly 100% while the benign group was validated with nearly 90% accuracy. 
Though the benign accuracy fell by 3% relative to the prior LDA-based k-fold results, the 
malignant accuracy rose by about 10%, marking a significant improvement for malignant 
classification. Furthermore, the nearly identical results reported by both sets of train / 
validation splits confirm the stability of the overall dataset. 
 
Figure 4.8. (a) ROC curves generated from stratified k-fold cross-validation using 10,000 repeats 
and a training / validation split ratio of 90% / 10%. (b) The procedure is repeated using a split 
ratio of 75% / 25%. The accuracies reported in both (a) and (b) are nearly identical. 
 
In conclusion, the successful differentiation of VOCs associated with healthy and 
cancerous individuals indicates the strong potential of DNA-NT sensor arrays as a 
screening method for ovarian cancer. Particularly promising is the consistently accurate 
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classification of early-stage samples which would place DNA-NTs above other clinical 
trials. Such results support the proposed advantage of early-stage cancer screening based 
on VOC biomarker detection over other techniques that lack the necessary sensitivity, 
possibly due to lack of signal. In the case of liquid biopsy, which attempts to collect 
circulating tumor DNA (ctDNA), there is necessarily a lack of ctDNA within early-stage 
cancer patients since the tumors at this point would be relatively small. On the other hand, 
it is plausible that even early-stage cancer can cause a response from the host’s immune 
system that is reflected in the VOC contents found within the patient’s bodily fluids or 
body odor. Another clinical advantage of DNA-NT screening is the apparently low rate of 
false positives boasted by the pattern-recognition algorithms. In a real clinical setting, 
avoiding a false positive diagnosis would mean preventing unnecessary treatments like 
chemotherapy that are often accompanied by troublesome side-effects. Overall, the results 
signify the promise for this technology in comparison to currently established techniques 
and motivate further development to manifest an effective screening technique for ovarian 
cancer screening. 
The performance of this technique could be enhanced by improving the various 
components of the e-nose system. To date, we have only explored chemical responses in 
the scope of ten distinct DNA sequences. By investigating new DNA oligomers, we could 
discover other sequences that offer orthogonal chemical sensing information that is not 
accessed by the original sequences. Unlike the current set of DNA oligomers, which were 
chosen randomly, new oligomers could be engineered to target particular VOC biomarkers 
for ovarian cancer discovered by GC/MS. Furthermore, testing new DNA oligomers allows 
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us to pick and choose the most successful sequences for this application. We intend to 
redesign our sensor array to increase the number of distinct sensor types from 10 to 100. 
This will increase the “chemical resolution” with which we probe the volatile headspaces 
of each plasma sample. It will also allow us to test a greater number of DNA oligomers at 
once in order to efficiently discover optimal sequences. We also aim to increase our sample 
size to better represent the chemical vapor signatures from various populations. This will 
enable us to utilize more specialized machine-learning methodologies to further improve 
the overall classification accuracy. 
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CHAPTER 5: Assessment of DNA-NT Performance for 
Remote Monitoring Applications 
 
This chapter presents potential uses of DNA-NT arrays in remote monitoring 
applications such as pollution detection and monitoring of agricultural produce. Various 
performance characteristics of DNA-NTs were investigated with a series of experiments 
designed to simulate certain complex environmental conditions related to such 
applications.  
 Section 5.1 motivates several desired qualities of ideal environmental chemical 
sensors, including low detection limits, detection of dilute targets in the presence of a 
complex background, fast chemical response readouts, and long lifetime. 
 Section 5.2 discusses experiments involving a freshly made DNA-NT array 
exposed to various concentrations of 2,6-dinitrotoluene (DNT). The array demonstrated 
sensitivity to parts-per-billion (ppb) concentrations of DNT. The experiment was repeated 
with exposure times reduced from two minutes to one minute. DNA-NT responses to the 
DNT were diminished but still visibly apparent after some signal processing, 
demonstrating high sensitivity and fast response times of our sensors. 
Section 5.3 discusses follow-up experiments involving the same array, this time 
exposed to DNT mixed with dimethyl methylphosphonate (DMMP) to simulate a complex 
background. DNA-NTs successfully distinguished 152 parts-per-million (ppm) DMMP 
from 152 ppm DMMP mixed with 149 ppb DNT, indicating sensitivity to a dilute target 
even in the presence of a 1000-times concentrated background. The fresh DNA-NT array 
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was replaced with another identical array that was prepared four months prior and the 
complex background experiment was repeated. Responses to DNT and DMMP mixtures 
were expectedly diminished, possibly due to partial denaturing of the sensing material. 
Nevertheless, the older array was also able to discriminate between mixtures with and 
without DNT. Thus, the DNA-NTs performed desirably in terms of sensitivity, selectivity, 





There is a strong desire for chemical vapor sensors that can operate in real-world 
settings with numerous potential uses in agricultural1-2, military,3-4 and environmental 
monitoring applications.5-10 Examples include assessment of ripeness or vitality of crops 
and produce, remote detection of mines in a warzone, and detection of pollutants in the 
atmosphere. In each case, chemical sensors must be able to identify target molecules in a 
complex chemical background. Furthermore, unlike laboratory settings where relative 
concentrations of VOC mixtures can be controlled precisely, the volatile backgrounds in 
real-world settings are constantly fluctuating which makes successful classification of 
VOCs more challenging. In practice, commercial sensors are often expected to collect vast 
amounts of data for extended periods of time, sometimes on the order of weeks or months. 
Because of this, sensors with low-power consumption and long lifetimes are preferred. Fast 
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measurement readouts are also coveted so as to capture as many VOC binding events as 
possible.  
 A series of experiments was initiated in collaboration with Rohinton Mehta’s group 
at X Development (Mountain View, CA) to assess the performance of our DNA-NTs in 
real-world environments. Five separate experiments were conducted within the laboratory 
using the e-nose system to simulate various environmental conditions. DNA-NT 
performance was evaluated based on the following desired characteristics: (1) detection of 
low concentrations of VOC analytes down to parts-per-billion levels; (2) detection of 
fractional changes of analyte concentration in the presence of a concentrated complex 
background; (3) fast responses to analytes; and (4) long-lasting devices that can remain 
functional for weeks or months.  
 
5.2 Parts-per-billion Detection of 2,6-Dinitrotoluene 
 
The first experiment sought to demonstrate parts-per-billion (ppb) sensitivity of the 
DNA-NTs. 2,6-Dinitrotoluene (DNT) was chosen as the target analyte due to its relatively 
low vapor pressure (5.67 ∙ 10−4 Torr).11 Roughly 10 mL of solid DNT powder was placed 
in a gas bubbler and allowed ample time to generate headspace volatiles. A fresh DNA-NT 
array with 80% device yield was prepared the day before the experiment. The array was 
initially exposed to two-minute pulses of DNT mixed with nitrogen at three different 
concentrations: 14.9 ppb, 149 ppb, and a fully saturated concentration of 746 ppb (Figure 
5.1a). Each pulse was followed by a two-minute refresh with pure nitrogen. Water vapor 
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was not included in the mixture to remove any doubt that the ensuing responses were 
caused by DNT alone. Exposure to DNT caused positive current shifts in DNA-NT 
currents, which was expected due to prior investigation.12 Responses to 149 ppb and 746 
ppb DNT were easily resolved. Responses to 14.9 ppb DNT were less profound and not 
easily resolved without additional data processing. Hence, all DNA-NT currents were 
baseline-fitted and then smoothed using 7-point boxcar averaging to improve signal-to-
noise. This revealed visibly apparent responses to 14.9 ppb DNT. 
 
 
Figure 5.1. (a) A day-old DNA-NT array was exposed to 2,6-dinitrotoluene (DNT) at various 
concentrations. Current responses are shown for a single Seq4 DNA-NT (blue). Responses are 
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clear for 149 ppb and 746 ppb concentrations of DNT, but less so for 14.9 ppb. A fitted current 
baseline (red) was subtracted from the raw current trace to reveal responses to 14.9 ppb DNT. 
(b) Average current responses for five DNA-NT sensor types (Seq1 through Seq5). The other five 
sensor types (Seq6 through Seq10) produced visually similar results and are not shown. 
Responses to 14.9 ppb DNT are small, yet visibly apparent. 149 ppb and 746 ppb responses are 
easily resolved. All averaged current responses were smoothed using 7-point boxcar averaging. 
 
The experiment was repeated with exposure and periods reduced from two minutes 
to one minute. DNA-NT currents were again baseline-fitted and smoothed using boxcar 
averaging. The response magnitudes were predictably reduced due to the lower exposure 
time. Nevertheless, Seq4 and Seq5 current responses were clearly resolved for all target 
concentrations while the other sensor groups also evidenced some detection capacity for 
14.9 ppb and 149 ppb DNT (Figure 5.2). These results demonstrate the desirably high 
sensitivity and fast response capabilities of DNA-NTs. 
 
Figure 5.2. DNT exposure times are reduced from two minutes to one minute. The responses are 
smaller as expected. Only Seq4 and Seq5 responses demonstrate apparent detection of 14.9 ppb 
and 149 ppb DNT. 
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5.3 Detection of DNT Target in Complex Background 
 
 The second experiment simulated detection of a target analyte in a complex 
background. The same day-old DNA-NT array was initially exposed to a mixture of DNT 
with dimethyl methylphosphonate (DMMP), a compound known to have a significantly 
larger vapor pressure (0.579 Torr) than DNT.13 The relative concentrations of DNT and 
DMMP were fixed at 149 ppb and 152 parts per million (ppm), respectively, thus creating 
a 1000-times diluted target-to-background mixture. After a one-minute exposure, the 
DNA-NTs were refreshed using 0% relatively humid (dry) nitrogen. This was followed by 
an exposure to 152 ppm DMMP devoid of DNT in the mixture. DMMP is known to cause 
negative shifts in DNA-NT currents,12 and since the DMMP was more concentrated, the 
responses to both types of pulses were expectedly negative. The DNA-NT responses were 
baseline-fitted and smoothed as before. This revealed that the current responses of the 
DNT-containing pulses were shifted slightly positive relative to responses to the DMMP 
background alone (Figure 5.3). Given that DNT exposures elicit positive responses, this 
result suggested that the presence of highly diluted DNT was indeed detected in the 1000-





Figure 5.3. DNA-NT responses to the 152 ppm DMMP + 149 ppb DNT mixture are superimposed 
with responses to only DMMP for comparison. All responses were smoothed using 7-point 
boxcar averaging. Solid lines represent the mixture and dashed lines are for the suppressed 
mixture. A slight relative positive shift in response is observed for the mixture containing DNT, 
suggesting that the DNA-NTs detected the lack of DNT molecules which are known to evoke 
positive current responses. 
 
 The DNT detection in complex background experiment was repeated using a four-
month-old DNA-NT array in place of the fresh array. The old array had not been used in 
any prior experiments and was merely kept in a plastic petri dish stored in air after it was 
fabricated. Up to this point, we had never observed responses of DNA-NT arrays more 
than a few weeks old and thus, it was not known whether the months-old array would 
reproduce the results from the previous experiment or if denaturing of the DNA had 
compromised its sensing capabilities. Despite its age, the array boasted a device yield of 
78% which was near that of the fresh array. As before, a one-minute exposure to 149 ppb 
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DNT with 152 ppm DMMP background was issued, followed by a one-minute exposure 
to 0 ppb DNT and 152 DMMP. The DNA-NTs were again refreshed with dry nitrogen in 
between each exposure. This cycle of measurements was repeated two more times and the 
average responses to each mixture were compared (Figure 5.4). The overall response 
magnitudes for the older array were diminished by roughly a factor of ten, suggesting that 
some denaturing of the sensing material had occurred. Nevertheless, a relative positive shift 
was observed for responses to mixtures containing DNT, thus reproducing the results of 
the fresh array. This result suggests a long-term shelf life of DNA-NTs projected on the 
order of months. 
 
 
Figure 5.4. The complex mixtures experiment was repeated using an DNA-NT array stored in air 
for four months. All responses were smoothed using 7-point boxcar averaging. The response 
profiles for 149 ppb DNT (solid line) and 0 ppb DNT (dashed line) represent averages of the three 
responses to each mixture. The overall response magnitudes for the older array were diminished 
by roughly a factor of ten, suggesting that some denaturing of the sensing material had occurred. 
However, the same relative positive shift was observed for responses to mixtures containing 
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DNT, confirming that the months-old DNA-NT array was able to reproduce the results of the fresh 
array. 
 
For certain applications, it may not be feasible to refresh the DNA-NTs with 
nitrogen after every exposure. To simulate the constant presence of a complex background, 
the latter experiment was repeated once more using a 152 ppm DMMP mixture as the 
refresh instead of dry nitrogen. The months-old array was exposed to alternating mixtures 
of 149 ppb DNT in DMMP background and plain DMMP background (Figure 5.5). Slight 
negative current shifts were observed in the absence of DNT in the mixture, validating the 
trend observed in the previous experiments and thus confirming the capability of DNA-
NTs to detect a dilute target despite the lack of a clean refresh. 
 
Figure 5.5. DNA-NT responses to pulses of 149 ppb DNT in 152 ppm DMMP background refreshed 
with 152 ppm DMMP instead of pure nitrogen. All responses were smoothed using 7-point boxcar 
averaging. The first pulse overresponded significantly, possibly due to unregulated buildup of 
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the DMMP headspace, and was therefore ignored. For the remaining responses, small yet 
apparent negative current shifts are observed in the absence of DNT in the mixture. 
 
In conclusion, our DNA-NTs demonstrated promising performance in terms of 
sensitivity, fast response, long lifetime, and ability to detect a dilute target in a highly 
concentrated complex background. Though X Development did not disclose their 
particular interests in this technology, it is conceivable that DNA-NT arrays can be used 
for long-term monitoring of crops or mounted on robotic devices programmed to roam 
warzones or other potentially hazardous environments in search of explosives or chemical 
weapons. Sensor performance can be further optimized according the specific application 
by tuning DNA-NT affinities towards the desired targets via specially engineered DNA 
sequences. Further performance enhancements may be realized by using more 
sophisticated baseline-fitting algorithms and noise reduction techniques. 
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CHAPTER 6: DNA-NT Screening for SARS-CoV-2 
Based on Human Sweat 
 
In this chapter, we discuss the deadly implications of the new coronavirus SARS-
CoV-2 that spread rapidly across the world and the need for efficient and accurate screening 
of large populations for the COVID-19 disease. Early identification of infection would 
allow medical experts and government officials to take effective preventative measures, 
such as enforcing strict quarantine regulations for densely populated urban centers that are 
at high risk of an outbreak. 
Section 6.1 introduces a pilot study initiated by our collaborator Dr. Cynthia Otto 
involving human sweat samples provided by individuals who had tested positive for 
COVID-19 (CoV+) as well as those who had been confirmed as COVID-negative (CoV-). 
The aim was to train scent detection dogs to discriminate between VOCs associated with 
the CoV+ and CoV- groups. All samples were shared with the Johnson Group for a 
complementary investigation using DNA-NT arrays. 
Section 6.2 describes experiments involving DNA-NT measurements of headspace 
VOCs from 30 sweat samples: fifteen from COVID-positive subjects and fifteen from 
COVID-negative individuals. The ensuing DNA-NT responses were processed using linear 
discriminant analysis (LDA) which revealed strong discrimination between the CoV+ and 
CoV- groups. An LDA-based binary classifier was constructed using estimated normal 
distributions associated with the two groups. The classifier demonstrated degrees of 
sensitivity and specificity which are comparable to what is currently reported for reverse 
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transcription polymerase chain reaction (RT-PCR), one of the established screening 
techniques used for COVID-19 today. A receiver operating characteristic (ROC) curve was 
also generated using the CoV+ and CoV- distributions from which a 99% classification 
accuracy was estimated for the LDA binary classifier. These compelling results suggest 





  A new strain of coronavirus, severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2), emerged in Wuhan, China during the winter of 2019 and spread rapidly 
around the world.1 Those infected with the virus develop coronavirus disease 2019 
(COVID-19) with potentially severe or deadly outcomes.2 This is the third coronavirus 
outbreak within the past twenty years and is by far the most infectious to humans with over 
58 million reported cases and nearly 1.4 million deaths worldwide as of November 15, 
2020.1-2 The United States leads the world in both figures with over 12 million cases and 
250,000 deaths.1 Though there has been progress towards a vaccination for preventing the 
illness, none have yet been approved by the U. S. Food and Drug Administration.3 
Furthermore, developing accurate screening tests is challenging due to the novelty of 
COVID-19. Current detection approaches utilize reverse transcription polymerase chain 
reaction (RT-PCR) as well as antigen and antibody tests.4 Reports of sensitivity for RT-
PCR tests are largely uncertain, ranging from about 70% to 98%, while specificities are 
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estimated at roughly 95%.5 The accuracies of antigen and antibody tests are even less 
certain as each suffers from high false negative rates.4 A sensing technology that can permit 
effective and efficient screening of large populations would help reduce the rate at which 
COVID-19 spreads, particularly in airports, hospitals, and other potentially densely 
populated areas. 
A pilot study was initiated by our collaborator Dr. Cynthia Otto at the Penn Vet 
Working Dog Center, University of Pennsylvania, with the aim of training scent detection 
dogs and using DNA-NT arrays to discriminate between human sweat samples from 
COVID-19 positive (CoV+) subjects and COVID-19 negative (CoV-) individuals. Dr. Otto 
established an online system through which volunteers could apply to donate sweat 
samples through the mail. Only volunteers who had been tested for COVID-19 were 
eligible for selection. Each volunteer was provided a brand new 100% cotton T-shirt and 
was given instructions to wear it to sleep for one night. The T-shirt would absorb sweat 
generated from the volunteer throughout the night. Each shirt was isolated inside a Ziploc 
bag for 24 hours before being returned to Dr. Otto in order to extinguish any lingering 
active viruses inhabiting the samples.6 All shirts were transported and handled in a BSL2 
biosafety hood to satisfy University of Pennsylvania regulations for COVID-19 research. 
Due to their high sweat content, portions from the sleeves, back, and chest areas were cut 
from each shirt and placed in individual glass jars for VOC preservation. Samples were 




6.2 DNA-NT Measurements of Human Sweat Samples 
 
DNA-NT sensor arrays functionalized with ten DNA oligomers listed in Table 3.1 
were used to measure headspace VOCs from fifteen COVID positive (CoV+) and fifteen 
COVID negative (CoV-) T-shirt samples. Strips of cloth were cut from the T-shirt sleeves 
using scissors cleaned with isopropanol and loaded into separate 25 mL round-bottom 
flasks. The samples were heated to 50 °C and were allowed 15 minutes to generate 
headspace VOCs. These were subsequently delivered to a ten-channel DNA-NT array for 
two minutes at a time using 67% RH nitrogen. Small yet distinguishable responses to the 
sample VOCs were observed (Figure 6.1). 
 
Figure 6.1. Average responses to eight Seq9 DNA-NT sensors exposed to headspace VOCs from 
two CoV+ and one CoV- T-shirt sleeve samples. Two cycles of measurements are shown to 
demonstrate signal reproducibility. The responses are small compared to those associated with 
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blood plasma, which are typically on the order of 10%. Nevertheless, the signal-to-noise ratios 
of the response averages are comparable to those observed for plasma. 
 
The ten-channel DNA-NT response data was processed using linear discriminant 
analysis (LDA). Response projections onto the first discriminant revealed strong separation 
between the CoV+ and CoV- groups (Figure 6.2). Given the lack of overlap between the 
clusters, a classification boundary line between them could easily be imagined that would 
result in perfect binary classification of all data. For a more informed estimation of the 
classifier’s diagnostic accuracy, Gaussian distributions were approximated for each cluster 
based on their respective means and standard deviations in order to simulate overlap 
between the groups. The false positive (false negative) rate was calculated by dividing the 
area of the overlapped region of the CoV+ (CoV-) distribution by the area of the non-
overlapped region. 
 
Figure 6.2. LDA projections of DNA-NT responses to fifteen CoV+ and fifteen CoV- T-shirt 
samples are represented as colored triangles along the first linear discriminant (LDA1) with 
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associated Gaussian distributions based on the computed means and standard deviations of 
each cluster. The dashed line through the intersection between the curves indicates a binary 
classification boundary which defines the true positive, false positive, true negative, and false 
negative regions (labeled as TP, FP, TN, and FN, respectively). 
 
The sensitivity and specificity for the binary classifier were also estimated based 
on the Gaussian distributions from Figure 6.2. Sensitivity measures the fraction of CoV+ 
cases that were correctly identified as positive while specificity measures the fraction of 
CoV- cases that were correctly classified as negative (6.2.1): 
 
where TPR, TNR, FPR, and FNR are the true positive, true negative, false positive, and 
false negative rates, respectively. The calculated DNA-NT sensitivity was 93.5% and the 
selectivity was 95.8% which is comparable to the most optimistic estimates for RT-PCR 
tests. The diagnostic accuracy of the binary classifier based on the two Gaussian 
distributions was also estimated using a receiver operating characteristic (ROC) curve 
(Figure 6.3). The area under the curve indicated a 99% probability of correctly 



























Figure 6.3. Receiver operating characteristic for the estimated normal distributions from Figure 
6.2. The area under the curve indicates a 99% probability of correctly distinguishing CoV+ and 
CoV- data. 
 
In conclusion, DNA-NT sensors demonstrated a strong capacity to differentiate 
between headspace VOCs from human CoV+ sweat and CoV- sweat in this initial proof-
of-concept investigation. The success of the DNA-NT sensors is particularly impressive in 
this case because they were immediately adaptable to discriminating between VOCs 
associated with such a new disease, alluding to the flexibility of the technology. 
Advantages of this e-nose approach include speed of development, on-site prompt testing 
potential, guaranteed safety to both the patient and the caretaker, and relatively low cost of 
deployment. Furthermore, because only human sweat is needed as a specimen, this 




These compelling results motivate further development of an e-nose approach to 
screening populations for the COVID-19 disease. In order to build further acclaim for this 
screening method, we plan to increase our sample database up to 400 CoV- and 200 CoV+ 
individuals. As is discussed in previous chapters, we also have the opportunity to improve 
our selection of DNA oligomers to further increase the discrimination power of the DNA-
NTs, perhaps by targeting specific characteristics of biomarker molecules discovered by 
GC/MS that are associated with COVID-19. Finally, the success of LDA-based data 
processing suggests the possibility of using more sophisticated machine learning 
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Chapter 7: Summary, Conclusions and Future Work 
 
 
In this work, progress was made in developing an e-nose system based on DNA-
NT arrays capable of screening individuals for ovarian cancer and COVID-19 using human 
blood plasma and sweat, respectively. In addition, DNA-NTs were shown to have desirable 
attributes in terms of parts-per-billion (ppb) limits of detection, the ability to detect low 
concentrations of target VOCs in the presence of a highly concentrated background, fast 
responses on the order of seconds, and lifetimes on the order of months. The successes 
enjoyed by the DNA-NTs suggest significant promise for their utility in disease diagnostics 
as well as various environmental monitoring applications such as pollution detection. 
These vapor sensors possess exquisite sensitivity that has only recently become 
available due to the technological breakthroughs and advancements in the fields of 
nanotechnology and bioengineering and rise up to the challenge posed by early-stage 
disease detection where very small concentration of one or several compounds is present. 
Furthermore, despite the fact that the identities of relevant VOC compounds are often not 
completely known, DNA-NT arrays have demonstrated a desirable ability to differentiate 
between informative vapor species using the same principles that govern the discrimination 
capabilities of mammalian olfaction systems found in nature.  
In addition, DNA-NTs enjoy numerous attributes that make them ideal candidates 
for hospital use or remote monitoring of various environments. Because they are fast-
responding, cost-efficient, and easy to use by non-technical personnel, e-nose systems 
based on DNA-NTs are ideal for on-site prompt testing. These characteristics are clear 
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advantages over expensive and highly complex analytical techniques such as gas 
chromatography / mass spectrometry (GC/MS) which are cumbersome and suffer from 
slow readouts. Given their function of probing compounds in the vapor phase, DNA-NTs 
are also generally non-intrusive as the possibility of direct contamination of the sensor (or 
contamination of the sample from the sensor) is reduced. 
The fabrication of vapor sensor arrays is simple and can also be customized and 
tailored towards specific applications by choosing the DNA oligomers that work best for 
detecting certain molecules. Thus, as researchers develop a more complete understanding 
of the volatile metabolites in bodily tissues or fluids that indicate the presence of particular 
diseases of interest, the DNA-NT arrays can be evolved for improved screening 
performance. 
 In medical practice, clinical screening always yields false positives and negatives 
due to biological variations between individuals and countless other sources. Both forms 
of experimental error are of clinical concern. False negatives occur when a screening fails 
to identify the presence of a condition. This is especially problematic for diseases like 
ovarian cancer that can only be treated reliably in the early stages. A false negative in this 
case would often be fatal as the cancer would be able to metastasize unbeknownst to 
caretakers and patients alike until it is too late to treat the patient. With such high stakes, 
false negatives reduce the confidence of the medical community that the screening 
technology is worthwhile. False positives have dramatic consequences as well. False 
positives will put healthy individuals through unnecessary follow-up examinations such as 
biopsies. These tests are often harmful to the patients that receive them, and the overall 
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process can cause a great deal of needless anxiety. Moreover, biopsies are arduous and 
expensive procedures, and too many false positives will put strain on hospitals that have 
limited resources in terms of personnel, equipment, and funds. 
 The DNA-NT arrays have already demonstrated promising performance in terms 
of false positives and negatives. However, this technology has yet to see extensive testing 
in a real hospital setting. To curtail some of the worry surrounding false predictions, DNA-
NTs can be combined with other techniques that could provide orthogonal information to 
increase the probability of identifying important features in samples that would ultimately 
lead to improved classification performance. This is easily imaginable, as vapor-phase 






Appendix A: Basic Mathematical Foundations of Machine Learning 
Algorithms 
 
Appendix A.1: Principal Component Analysis 
The general procedure of PCA is to represent a data set with a basis that will best 
distinguish significant parameter correlations from signal noise. We start by imagining a 
data set acquired from a 10-channel NTFET array exposed to VOCs from n different trials. 
We define 𝑿 = {𝑥 1, 𝑥 2, … 𝑥 10} as the set of ten-dimensional NTFET outputs where the 
column vector 𝑥 1 represents the Seq1 responses, 𝑥 2 represents the Seq2 responses, and so 
on. Important trends are easily revealed when the signal-to-noise ratios (SNRs) of the 
responses are high, and much less so when the SNRs are low. The response signals are 
associated with the variances of 𝑥 1, 𝑥 2, … 𝑥 10. Meanwhile, NTFET responses are also 
strongly correlated because they are highly cross-sensitive. This is an indication that much 
of the information in the output data is redundant. Thus, we consider the covariances 

















We now want to represent 𝑿 in a basis more suitable to revealing only the most 
important information with as few parameters as necessary. To do this, we apply a linear 
transformation on 𝑿: 
𝑷𝑿 = 𝒀 
where 𝑷 is an orthonormal matrix. This transformation essentially rotates the 
representation of 𝑿 to a new set of axes encoded in the rows of 𝑷. The best choice of 𝑷 
associates only a few principal components with high measures of SNR – that is to say, 
maximizing the response signals, measured by the variances, and minimizing redundancy, 













Since 𝑿𝑿𝑻 is a symmetric matrix, it can be diagonalized by 𝑿𝑿𝑻 = 𝑽𝑫𝑽𝑇. Here, the 
columns of 𝑽 are the eigenvectors of 𝑿𝑿𝑻 and 𝑫 is a diagonal matrix whose elements are 











In this way, the procedure for PCA is reduced to solving a generalized eigenvalue for 𝑿𝑿𝑻. 
 
Appendix A.2: Linear Discriminant Analysis 
We imagine a data set where each data point, 𝑣𝑖, represents ten response averages 
(Seq1, Seq2, and so on). We define the basis 𝑽 ∈ ℝ such that each 10-dimensional data 
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point {𝑣1, 𝑣2, 𝑣3, 𝑣4, … 𝑣𝑁} ∈ 𝑽 where N is the total number of data points. Our mission is 
to find a transformation that maps 𝑽 → 𝒀 where 𝒀 is the basis with maximized class 
separation. For simplicity, we assume there are only two classes with N1 data points in 





























. To maximize the separation between class distributions, 
we will need two properties: (1) the relative positions of each distribution in space and (2) 
the degree of spread within each distribution. 
Starting with first property, let 𝜇𝑖 be the centroid of distribution of the i
th class 








Transforming this to the 𝒀 basis, we obtain: 



















We now define a measure of the “offset” between distributions: 
(𝜇1 − 𝜇2)
2 = (𝑤𝑇𝜇1 − 𝑤
𝑇𝜇2)
2 = 𝑤𝑇(𝜇1 − 𝜇2)(𝜇1 − 𝜇2)
𝑇𝑤 = 𝑤𝑇𝑺𝑩𝑤 = ?̃?𝑩 
Here, 𝑺𝑩 is the between-class scatter matrix for samples in the 𝑽 space while ?̃?𝑩 is same 
matrix represented in the 𝒀 basis. 

















We can define a within-class scatter matrix 𝑺𝒊 for each class as the following: 
𝑠?̃?










Then the total within-class scatter for the entire data set is defined as the sum of these terms 
for each class: 
𝑠1̃
2 + 𝑠2̃
2 = 𝑤𝑇(𝑺𝟏 + 𝑺𝟐)𝑤 = 𝑤
𝑇𝑺𝑾𝑤 = ?̃?𝑾 
where 𝑺𝑾 and ?̃?𝑾 are the complete within-class scatter matrices for the entire data set in 
bases 𝑽 and 𝒀, respectively. 
The transformation 𝑦 = 𝑤𝑇𝑣 the between-class separation relative to the overall within-



















) = 0 






−𝟏𝑺𝑩𝑤 − 𝐽(𝑤)𝑤 = 0 
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We are now faced with a generalized eigenvalue problem where 𝑺𝑾
−𝟏𝑺𝑩 = 𝜆𝑤. Here, the 
eigenvalue 𝜆 = 𝐽(𝑤). We can finally solve for 𝑤: 
 
This is the general solution for the optimized basis for maximizing the separation between 




Appendix B: Fabrication Procedures for DNA-Functionalized NTFET 
Arrays 
 
Appendix B.1: Photolithography Process 
 
Deposit 15nm of Al2O3 on standard Si/SiO2 wafer. Then follow the steps below: 
 
1.) Pre-bake 
Dehydration bake: ~150°C, ~ 2mins. 
 
2.) Primer 
Spin PMGI: 4000 rpm, 45s, 500 rpm/s 
Bake at 210°C for 5 minutes 
 
3.) Photoresist 
Spin S1813: 5000 rpm, 45s, 500 rpm/s 
Bake at 100°C for 2 minutes 
 
4.) UV Light Exposure 
Use a hard contact procedure with manual alignment. Exposure dose is 120 mJ/cm2. Use 
the mask-aligner camera to make sure the common source electrode for column 10 is not 






Immerse substrate in MF-319 developer for around 30-60s. Use a pipette to agitate and 
disperse dissolving resist away from surface. The features of the pattern should gradually 
appear and change color due to the changing thickness of the resist. Once the surface is a 
uniform dark purple, remove the wafer from the developer and immediately rinse with 




Normally evaporate 5 nm Cr / 40 nm Au 
  
7.) Lift-off 
Use R1165 remover to lift-off leftover resist. Leave the wafer soaking overnight and then 
heat the remover to 60°C. Use a pipette to agitate the solvent so that every last bit of 
residual photoresist is dissolved. Sometimes sonication is needed to resolve finer features. 
When the desired pattern is fully resolved, transfer the wafer to an acetone bath for 10 min 






Appendix B.2: CNT Deposition 
 
1. Acquire one large petri dish (bottom and cover), one small petri dish (cover only), 
and one glass slide. Place glass slide and small cover in the large bottom. 
2. If sonication is needed, pipette desired volume of CNT solution in a 1.5 mL aliquot 
vial and place vial in a foam “floater.” Place in the small sonicator and sonicate for 
desired duration. 
3. Choose array(s) for CNT deposition and blow off with N2 gas. Place chips on the 
glass slide. 
4. Start boiling DI water. 
5. Drop-cast roughly 130 – 140 µL of CNT solution for each array.  
6. Pour boiling water into small cover. Cover everything with the large cover and set a 
timer for 30 min. 
7. When the timer goes off, remove the top cover and the water container. Pour 
isopropanol directly into the large bottom so that the chips are fully immersed in 
solvent. 
8. Set a timer for 15 minutes. Agitate the IPA bath every 3 minutes. 
9. Transfer to a water bath. Be sure to prevent the chips from drying out during the 
transfer by spraying each chip with water from a squirt bottle while it is exposed to 
the air. 
10. Set timer for 5 minutes. 
11. Repeat steps 9 and 10 two more times. 
12. Blow each chip dry with N2 gas. 
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13. Set each chip on a hot plate set at 165ºC. Set a timer for 1 hour. 





Appendix B.3: DNA Deposition 
 
1. Acquire materials- 1 large petri dish (bottom and cover), 1 small petri dish (cover 
only), and 1 glass slide. Place glass slide and small cover in the large bottom. 
2. Thaw aliquots of desired DNA sequences (usually I use Seq1 through Seq10) 
3. Choose array for DNA deposition and blow off with N2 gas. Place the chip on the glass 
slide. 
4. Start boiling DI water. 
5. Pipette roughly 1.8 – 1.9 µL of DNA onto the regions shown below: 
 
6. Fill the small petri dish with hot water and close the cover of humidity bath. 
7. Set a timer for 30 minutes. 
8. Remove the chip from the humidity bath. Use the nitrogen gun to carefully blow the 
five leftmost droplets off the left side of the chip one at a time (corresponding to Seq1 – 













Appendix C: Tabulated Ovarian Plasma Responses 
 
Current responses to VOCs from the 58 individual plasma samples. Each response 
value represents the percent variation from baseline, ΔI/I0, for all sensors of a given sensor 
type. The sample set consists of 21 healthy samples, 16 benign samples, and 21 malignant 
samples, of which five were from women with Stage I/II ovarian cancer. Variations in 


























5 -3.84 -0.60 -2.24 -1.79 -2.95 -2.17 -2.26 -4.31 -3.37 -4.45 
3 -4.74 -1.71 -3.44 -3.21 -7.06 -3.39 -2.55 -6.60 -4.65 -5.13 
13 -3.26 -0.90 -2.00 -1.82 -3.71 -2.03 -1.92 -4.06 -2.98 -3.61 
15 -3.04 -0.95 -1.91 -1.90 -4.42 -1.45 -2.36 -4.45 -2.99 -3.19 
7 -3.38 -0.72 -2.12 -1.84 -3.82 -2.03 -2.18 -4.91 -2.80 -4.05 
14 -1.97 -1.12 -0.81 -0.88 -1.85 -0.85 -0.81 -1.84 -1.10 -1.29 
9 -1.87 -1.26 -0.77 -0.79 -1.36 -0.75 -0.84 -1.84 -0.94 -1.24 
18 -1.65 -1.11 -0.83 -0.81 -1.66 -0.67 -0.95 -1.89 -1.13 -1.32 
17 -1.72 -1.08 -0.69 -0.75 -1.24 -0.58 -0.85 -1.66 -1.04 -1.20 
B10 -2.91 -1.17 -1.79 -1.33 -3.68 -1.84 -1.57 -3.47 -2.00 -2.68 
B16 -3.08 -1.10 -1.76 -1.65 -3.01 -1.57 -1.54 -4.09 -2.81 -2.63 
D21 -2.71 -0.96 -1.40 -1.50 -3.67 -1.47 -1.79 -3.22 -2.57 -2.52 
C7 -2.75 -1.03 -1.61 -1.49 -3.38 -1.60 -1.93 -3.69 -2.21 -2.99 
C24 -2.97 -1.07 -1.28 -1.24 -3.51 -1.25 -1.55 -2.88 -2.21 -3.06 
C30 -3.12 -1.04 -1.57 -1.57 -2.56 -1.63 -1.65 -3.30 -2.45 -2.72 
D8 -3.39 -1.03 -1.58 -1.43 -3.18 -1.62 -1.64 -3.28 -2.59 -3.12 
D26 -3.03 -1.02 -1.69 -1.73 -3.00 -1.25 -1.69 -3.62 -2.94 -2.47 
D31 -3.13 -1.06 -1.81 -1.67 -3.64 -1.49 -1.68 -3.79 -2.45 -3.16 
D36 -2.69 -0.91 -1.62 -1.48 -3.47 -1.45 -1.36 -3.75 -2.21 -2.50 
D56 -2.60 -0.98 -1.71 -1.45 -2.99 -1.31 -1.66 -3.95 -2.36 -2.34 
D59 -3.25 -1.20 -1.93 -1.61 -3.16 -1.67 -1.56 -3.79 -2.68 -3.22 
Benign 
54 -2.18 -1.57 -1.33 -1.09 -1.46 -1.24 -0.96 -2.72 -1.95 -2.00 
53 -2.27 -1.80 -1.38 -1.18 -1.24 -1.27 -1.19 -2.70 -2.01 -2.21 
58 -2.33 -1.91 -1.38 -1.27 -2.14 -1.32 -1.17 -2.94 -2.08 -2.06 
64 -1.32 -1.21 -0.57 -0.50 -0.96 -0.42 -0.94 -1.09 -0.98 -1.02 
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56 -1.97 -1.64 -1.16 -0.96 -1.07 -0.93 -1.16 -2.36 -1.56 -1.79 
H5837 -2.19 -1.69 -1.12 -0.98 -1.30 -1.05 -1.15 -2.14 -1.61 -1.68 
H6032-8 -2.06 -1.13 -1.18 -1.05 -1.44 -0.85 -1.13 -2.47 -1.63 -1.86 
H6001-
11 -2.12 -1.59 -1.14 -1.06 -1.48 -0.71 -1.01 -2.37 -1.62 -1.67 
H6130-
10 -1.89 -1.65 -1.21 -1.05 -1.49 -1.01 -1.08 -2.07 -1.71 -1.84 
H6153-6 -1.86 -1.63 -1.11 -0.98 -1.32 -1.15 -1.07 -2.45 -1.71 -1.84 
H5869 -2.05 -1.65 -1.22 -0.97 -1.39 -0.99 -1.01 -2.40 -1.70 -1.71 
H6019-4 -2.08 -1.71 -1.13 -0.89 -1.37 -0.83 -1.14 -2.23 -1.63 -1.89 
H6044-5 -2.12 -1.48 -1.11 -1.08 -1.48 -1.05 -1.14 -2.33 -1.76 -1.89 
H6057-7 -1.96 -1.64 -1.17 -0.98 -1.49 -0.84 -0.93 -2.28 -1.53 -1.95 
H6145-2 -1.94 -1.47 -1.24 -1.13 -1.32 -0.98 -1.11 -2.43 -1.85 -1.63 
H6151-6 -2.17 -1.69 -1.14 -0.99 -1.19 -1.12 -1.12 -2.39 -1.75 -1.69 
Malignant 
49 -2.25 -1.54 -3.15 -3.33 -2.26 -2.62 -1.10 -4.61 -5.44 -3.87 
46 -6.67 -2.16 -4.40 -7.15 -9.63 -3.97 -6.97 -7.54 -5.30 -7.83 
52 -2.02 -0.95 -2.97 -2.14 -2.07 -2.33 -1.19 -2.83 -3.50 -3.00 
57 -1.39 -0.72 -3.17 -1.88 -2.62 -0.31 -1.85 -2.16 -3.27 -1.74 
50 -1.39 -0.74 -3.55 -1.89 -4.16 -1.04 -2.80 -2.56 -2.23 -2.26 
48 -1.63 -1.60 -0.94 -1.15 -1.36 -0.89 -1.54 -1.84 -1.35 -1.48 
45 -2.21 -2.39 -1.42 -1.59 -2.41 -1.75 -1.17 -2.98 -1.98 -1.80 
66* -2.19 -1.56 -1.08 -1.14 -1.54 -1.16 -1.83 -2.25 -1.62 -1.69 
68 -1.96 -1.29 -1.00 -1.07 -1.58 -1.03 -1.51 -2.14 -1.56 -1.54 
65 -1.9 -2.11 -0.87 -0.96 -1.29 -0.78 -1.46 -2.14 -1.38 -1.46 
H6035-
14 -2.39 -1.53 -2.07 -2.04 -3.00 -1.64 -1.93 -2.74 -2.92 -2.42 
H5919-
10 -2.47 -1.61 -2.62 -2.49 -2.53 -1.59 -2.24 -2.65 -2.90 -2.67 
H6017-
16 -2.24 -1.57 -2.24 -2.28 -2.45 -1.50 -2.04 -3.11 -3.09 -3.11 
H6133-9 -2.13 -1.44 -2.23 -1.94 -2.55 -1.74 -2.10 -3.28 -2.53 -2.72 
4451-C-
1210* -2.12 -1.45 -2.20 -1.83 -2.40 -1.72 -2.50 -3.13 -2.75 -2.47 
H5877* -2.26 -1.57 -2.32 -2.23 -2.78 -1.55 -1.97 -3.23 -2.79 -2.50 
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